Potential genetic markers for wool quality traits reported by various researchers.
\\n\\n
\\n"}]',published:!0,mainMedia:{caption:"Milestone",originalUrl:"/media/original/124"}},components:[{type:"htmlEditorComponent",content:'
Barely three months into the new year and we are happy to announce a monumental milestone reached - 150 million downloads.
\n\nThis achievement solidifies IntechOpen’s place as a pioneer in Open Access publishing and the home to some of the most relevant scientific research available through Open Access.
\n\nWe are so proud to have worked with so many bright minds throughout the years who have helped us spread knowledge through the power of Open Access and we look forward to continuing to support some of the greatest thinkers of our day.
\n\nThank you for making IntechOpen your place of learning, sharing, and discovery, and here’s to 150 million more!
\n\n\n\n\n'}],latestNews:[{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"},{slug:"introducing-intechopen-book-series-a-new-publishing-format-for-oa-books-20210915",title:"Introducing IntechOpen Book Series - A New Publishing Format for OA Books"}]},book:{item:{type:"book",id:"2818",leadTitle:null,fullTitle:"Aneurysm",title:"Aneurysm",subtitle:null,reviewType:"peer-reviewed",abstract:"This book's focus is on diagnosis and treatment of intracranial aneurysm, abdominal and thoracic aortic aneurysms. It addresses neurosurgical, vascular and cardiothoracic surgeons and interventional radiologists, but also anyone engaged in vascular medicine. It presents is an effort to collect an up-to-date account of existing knowledge, involving recent developments in this field. Various experts described details of established knowledge or newly recognized advances associated with diagnosis, treatment, perioperative management and mechanism. This is the first book that deals with the whole body aneurysm, such as cerebral aneurysm, abdominal aneurysm, and splenial aneurysm and to learn the latest developments in other fields is always useful. I hope this book will be used worldwide by vascular surgeons and interventionalists enhancing their knowledge and stimulating the advancement of this field.",isbn:null,printIsbn:"978-953-51-0730-9",pdfIsbn:"978-953-51-7025-9",doi:"10.5772/3152",price:139,priceEur:155,priceUsd:179,slug:"aneurysm",numberOfPages:488,isOpenForSubmission:!1,isInWos:1,isInBkci:!1,hash:"70d1e8d9391850d228c30e307c25f534",bookSignature:"Yasuo Murai",publishedDate:"August 29th 2012",coverURL:"https://cdn.intechopen.com/books/images_new/2818.jpg",numberOfDownloads:62642,numberOfWosCitations:30,numberOfCrossrefCitations:23,numberOfCrossrefCitationsByBook:1,numberOfDimensionsCitations:56,numberOfDimensionsCitationsByBook:1,hasAltmetrics:1,numberOfTotalCitations:109,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"November 23rd 2011",dateEndSecondStepPublish:"December 21st 2011",dateEndThirdStepPublish:"March 29th 2012",dateEndFourthStepPublish:"June 17th 2012",dateEndFifthStepPublish:"July 17th 2012",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"147938",title:"Dr.",name:"Yasuo",middleName:null,surname:"Murai",slug:"yasuo-murai",fullName:"Yasuo Murai",profilePictureURL:"https://mts.intechopen.com/storage/users/147938/images/system/147938.jpg",biography:"Dr. Yasuo Murai MD, PhD who graduated from Nippon Medical School in 1993, trained at the Department of Neurosurgery, Nippon Medical School and specialized in Neurovascular surgery and skull base surgery at the Nippon Medical School hospital. His areas of expertise include neurovascular surgery, vascular reconstructive surgery and skull base neurosurgery both within Japan and abroad. A highly respected surgeon, teacher and researcher, he is one of the leading authorities on advanced vascular reconstructive surgery in Japan. He is the author of many peer-reviewed articles on these topics. He has been serving as acting head of the Nippon Medical School of neurovascular surgery and is an internationally recognized authority in vascular reconstructive surgery. He is currently clinical Assistant Professor of the Department of Neurosurgery at the Nippon Medical School hospital. He has received numerous scientific awards for his contributions to neurovascular surgery within Japan",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"1",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"985",title:"Cardiogeriatrics",slug:"cardiogeriatrics"}],chapters:[{id:"38639",title:"Biomechanics and FE Modelling of Aneurysm: Review and Advances in Computational Models",doi:"10.5772/46030",slug:"biomechanics-and-fe-modelling-of-aneurysm-review-and-advances-in-computational-models",totalDownloads:2680,totalCrossrefCites:7,totalDimensionsCites:14,hasAltmetrics:0,abstract:null,signatures:"Simona Celi and Sergio Berti",downloadPdfUrl:"/chapter/pdf-download/38639",previewPdfUrl:"/chapter/pdf-preview/38639",authors:[{id:"147448",title:"PhD.",name:"Simona",surname:"Celi",slug:"simona-celi",fullName:"Simona Celi"},{id:"148313",title:"Dr.",name:"Sergio",surname:"Berti",slug:"sergio-berti",fullName:"Sergio Berti"}],corrections:null},{id:"38626",title:"Mineral Components in Aneurysms",doi:"10.5772/47802",slug:"mineral-components-in-aneurysms",totalDownloads:2399,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Katarzyna Socha and Maria H. Borawska",downloadPdfUrl:"/chapter/pdf-download/38626",previewPdfUrl:"/chapter/pdf-preview/38626",authors:[{id:"144228",title:"Dr.",name:"Katarzyna",surname:"Socha",slug:"katarzyna-socha",fullName:"Katarzyna Socha"},{id:"145490",title:"Prof.",name:"Maria",surname:"Borawska",slug:"maria-borawska",fullName:"Maria Borawska"}],corrections:null},{id:"38633",title:"Main Models of Experimental Saccular Aneurysm in Animals",doi:"10.5772/50310",slug:"main-models-of-experimental-saccular-aneurysm-in-animals",totalDownloads:2566,totalCrossrefCites:2,totalDimensionsCites:3,hasAltmetrics:1,abstract:null,signatures:"Ivanilson Alves de Oliveira",downloadPdfUrl:"/chapter/pdf-download/38633",previewPdfUrl:"/chapter/pdf-preview/38633",authors:[{id:"147760",title:"PhD.",name:"Ivanilson Alves",surname:"De Oliveira",slug:"ivanilson-alves-de-oliveira",fullName:"Ivanilson Alves De Oliveira"}],corrections:null},{id:"38629",title:"The Role of Metalloproteinases in the Development of Aneurysm",doi:"10.5772/47792",slug:"the-role-of-metalloproteinases-in-the-development-of-aneurysm",totalDownloads:1775,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Krzysztof Siemianowicz",downloadPdfUrl:"/chapter/pdf-download/38629",previewPdfUrl:"/chapter/pdf-preview/38629",authors:[{id:"149042",title:"Dr.",name:"Krzysztof",surname:"Siemianowicz",slug:"krzysztof-siemianowicz",fullName:"Krzysztof Siemianowicz"}],corrections:null},{id:"38616",title:"Biomechanical Approach to Improve the Abdominal Aortic Aneurysm (AAA) Rupture Risk Prediction",doi:"10.5772/46032",slug:"biomechanical-approach-to-improve-the-abdominal-aortic-aneurysm-aaa-rupture-risk-prediction",totalDownloads:2204,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Guillermo Vilalta, Félix Nieto, Enrique San Norberto, María Ángeles Pérez, José A. Vilalta and Carlos Vaquero",downloadPdfUrl:"/chapter/pdf-download/38616",previewPdfUrl:"/chapter/pdf-preview/38616",authors:[{id:"142765",title:"Dr.",name:"Guillermo",surname:"Vilalta",slug:"guillermo-vilalta",fullName:"Guillermo Vilalta"}],corrections:null},{id:"38622",title:"Abdominal Aortic Aneurysm in Different Races Epidemiologic Features and Morphologic-Clinical Implications Evaluated by CT Aortography",doi:"10.5772/48379",slug:"abdominal-aortic-aneurysm-in-different-races-epidemiologic-features-and-morphologic-clinical-implica",totalDownloads:2467,totalCrossrefCites:1,totalDimensionsCites:2,hasAltmetrics:0,abstract:null,signatures:"Ana Mladenovic, Zeljko Markovic, Sandra Grujicic-Sipetic and Hideki Hyodoh",downloadPdfUrl:"/chapter/pdf-download/38622",previewPdfUrl:"/chapter/pdf-preview/38622",authors:[{id:"143132",title:"PhD.",name:"Ana",surname:"Mladenovic",slug:"ana-mladenovic",fullName:"Ana Mladenovic"},{id:"143962",title:"Prof.",name:"Zeljko",surname:"Markovic",slug:"zeljko-markovic",fullName:"Zeljko Markovic"},{id:"145317",title:"Prof.",name:"Hideki",surname:"Hyodoh",slug:"hideki-hyodoh",fullName:"Hideki Hyodoh"},{id:"145319",title:"Prof.",name:"Sandra",surname:"Sipetic Grujicic",slug:"sandra-sipetic-grujicic",fullName:"Sandra Sipetic Grujicic"}],corrections:null},{id:"38615",title:"Splenic Artery Aneurysms",doi:"10.5772/46031",slug:"splenic-artery-aneurysms",totalDownloads:5631,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Ahmad Alsheikhly",downloadPdfUrl:"/chapter/pdf-download/38615",previewPdfUrl:"/chapter/pdf-preview/38615",authors:[{id:"144628",title:"Prof.",name:"Ahmad Subhy",surname:"Alsheikhly",slug:"ahmad-subhy-alsheikhly",fullName:"Ahmad Subhy Alsheikhly"}],corrections:null},{id:"38618",title:"Studying the Flow Dynamics Within Endografts in Abdominal Aortic Aneurysms",doi:"10.5772/46034",slug:"studying-the-flow-dynamics-within-endografts-in-abdominal-aortic-aneurysms",totalDownloads:2062,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Efstratios Georgakarakos, Antonios Xenakis, George S. Georgiadis, Konstantinos C. Kapoulas, Evagelos Nikolopoulos and Miltos Lazarides",downloadPdfUrl:"/chapter/pdf-download/38618",previewPdfUrl:"/chapter/pdf-preview/38618",authors:[{id:"46440",title:"Dr.",name:"Efstratios",surname:"Georgakarakos",slug:"efstratios-georgakarakos",fullName:"Efstratios Georgakarakos"}],corrections:null},{id:"38627",title:"Abdominal Aortic Aneurysms - Actual Therapeutic Strategies",doi:"10.5772/48596",slug:"abdominal-aortic-aneurysms-actual-therapeutic-strategies",totalDownloads:2547,totalCrossrefCites:3,totalDimensionsCites:5,hasAltmetrics:1,abstract:null,signatures:"Ionel Droc, Dieter Raithel and Blanca Calinescu",downloadPdfUrl:"/chapter/pdf-download/38627",previewPdfUrl:"/chapter/pdf-preview/38627",authors:[{id:"40410",title:"Prof.",name:"Dieter",surname:"Raithel",slug:"dieter-raithel",fullName:"Dieter Raithel"},{id:"146395",title:"PhD.",name:"Ionel",surname:"Droc",slug:"ionel-droc",fullName:"Ionel Droc"},{id:"148898",title:"Dr.",name:"Blanca",surname:"Calinescu",slug:"blanca-calinescu",fullName:"Blanca Calinescu"}],corrections:null},{id:"38630",title:"Simulation of Pulsatile Flow in Cerebral Aneurysms: From Medical Images to Flow and Forces",doi:"10.5772/47858",slug:"simulation-of-pulsatile-flow-in-cerebral-aneurysms-from-medical-images-to-flow-and-forces",totalDownloads:1634,totalCrossrefCites:3,totalDimensionsCites:6,hasAltmetrics:0,abstract:null,signatures:"Julia Mikhal, Cornelis H. Slump and Bernard J. Geurts",downloadPdfUrl:"/chapter/pdf-download/38630",previewPdfUrl:"/chapter/pdf-preview/38630",authors:[{id:"146666",title:"Dr.",name:"Julia",surname:"Mikhal",slug:"julia-mikhal",fullName:"Julia Mikhal"},{id:"148901",title:"Prof.",name:"Cornelis",surname:"Slump",slug:"cornelis-slump",fullName:"Cornelis Slump"},{id:"148902",title:"Prof.",name:"Bernard",surname:"Geurts",slug:"bernard-geurts",fullName:"Bernard Geurts"}],corrections:null},{id:"38641",title:"A (Near) Real-Time Simulation Method of Aneurysm Coil Embolization",doi:"10.5772/48635",slug:"a-near-real-time-simulation-method-of-aneurysm-coil-embolization",totalDownloads:2346,totalCrossrefCites:1,totalDimensionsCites:8,hasAltmetrics:0,abstract:null,signatures:"Yiyi Wei, Stéphane Cotin, Jérémie Dequidt, Christian Duriez, Jérémie Allard and Erwan Kerrien",downloadPdfUrl:"/chapter/pdf-download/38641",previewPdfUrl:"/chapter/pdf-preview/38641",authors:[{id:"30621",title:"Dr.",name:"Jérémie",surname:"Allard",slug:"jeremie-allard",fullName:"Jérémie Allard"},{id:"48963",title:"Dr.",name:"Christian",surname:"Duriez",slug:"christian-duriez",fullName:"Christian Duriez"},{id:"49488",title:"Dr.",name:"Jérémie",surname:"Dequidt",slug:"jeremie-dequidt",fullName:"Jérémie Dequidt"},{id:"49489",title:"Prof.",name:"Stéphane",surname:"Cotin",slug:"stephane-cotin",fullName:"Stéphane Cotin"},{id:"146978",title:"PhD.",name:"Yiyi",surname:"Wei",slug:"yiyi-wei",fullName:"Yiyi Wei"},{id:"155336",title:"Dr.",name:"Erwan",surname:"Kerrien",slug:"erwan-kerrien",fullName:"Erwan Kerrien"}],corrections:null},{id:"38625",title:"Endovascular Treatment of Internal Carotid and Vertebral Artery Aneurysms Using Covered Stents",doi:"10.5772/48733",slug:"endovascular-treatment-of-internal-carotid-and-vertebral-artery-aneurysms-using-covered-stents",totalDownloads:2440,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Ivan Vulev and Andrej Klepanec",downloadPdfUrl:"/chapter/pdf-download/38625",previewPdfUrl:"/chapter/pdf-preview/38625",authors:[{id:"148606",title:"PhD.",name:"Ivan",surname:"Vulev",slug:"ivan-vulev",fullName:"Ivan Vulev"},{id:"148609",title:"Dr.",name:"Andrej",surname:"Klepanec",slug:"andrej-klepanec",fullName:"Andrej Klepanec"}],corrections:null},{id:"38634",title:"Complications and Adverse Events Associated with Stent-Assisted Coiling of Wide-Neck Intracranial Aneurysms",doi:"10.5772/50571",slug:"complications-and-adverse-events-associated-with-stent-assisted-coiling-of-wide-neck-intracranial-an",totalDownloads:2613,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Xu Gao and Guobiao Liang",downloadPdfUrl:"/chapter/pdf-download/38634",previewPdfUrl:"/chapter/pdf-preview/38634",authors:[{id:"147140",title:"Dr.",name:"Guobiao",surname:"Liang",slug:"guobiao-liang",fullName:"Guobiao Liang"},{id:"147148",title:"Dr.",name:"Xu",surname:"Gao",slug:"xu-gao",fullName:"Xu Gao"}],corrections:null},{id:"38635",title:"Stent-Assisted Techniques for Intracranial Aneurysms",doi:"10.5772/51295",slug:"stent-assisted-techniques-for-intracranial-aneurysms",totalDownloads:3640,totalCrossrefCites:1,totalDimensionsCites:7,hasAltmetrics:0,abstract:null,signatures:"Igor Lima Maldonado and Alain Bonafé",downloadPdfUrl:"/chapter/pdf-download/38635",previewPdfUrl:"/chapter/pdf-preview/38635",authors:[{id:"143700",title:"Dr.",name:"Igor",surname:"Maldonado",slug:"igor-maldonado",fullName:"Igor Maldonado"},{id:"149060",title:"Prof.",name:"Alain",surname:"Bonafé",slug:"alain-bonafe",fullName:"Alain Bonafé"}],corrections:null},{id:"38620",title:"Retroperitoneal Haemorrhage as a Dangerous Complication of Endovascular Cerebral Aneurysmal Coiling",doi:"10.5772/46036",slug:"retroperitoneal-haemorrhage-as-a-dangerous-complication-of-endovascular-cerebral-aneurysmal-coiling",totalDownloads:3508,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Yasuo Murai and Akira Teramoto",downloadPdfUrl:"/chapter/pdf-download/38620",previewPdfUrl:"/chapter/pdf-preview/38620",authors:[{id:"147938",title:"Dr.",name:"Yasuo",surname:"Murai",slug:"yasuo-murai",fullName:"Yasuo Murai"},{id:"147939",title:"Prof.",name:"Akira",surname:"Teramoto",slug:"akira-teramoto",fullName:"Akira Teramoto"}],corrections:null},{id:"38624",title:"Intracranial and Extracranial Infectious Pseudoaneurysms",doi:"10.5772/48543",slug:"intracranial-and-extracranial-infectious-pseudoaneurysms",totalDownloads:2097,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Václav Procházka, Michaela Vávrová, Tomáš Jonszta, Daniel Czerný, Jan Krajča and Tomáš Hrbáč",downloadPdfUrl:"/chapter/pdf-download/38624",previewPdfUrl:"/chapter/pdf-preview/38624",authors:[{id:"78527",title:"Dr.",name:"Vaclav",surname:"Prochazka",slug:"vaclav-prochazka",fullName:"Vaclav Prochazka"},{id:"145610",title:"Dr.",name:"Michaela",surname:"Vavrova",slug:"michaela-vavrova",fullName:"Michaela Vavrova"}],corrections:null},{id:"38619",title:"Saphenous Vein Graft Aneurysms",doi:"10.5772/46035",slug:"saphenous-vein-graft-aneurysms",totalDownloads:1945,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"G. Kang and K. Kang",downloadPdfUrl:"/chapter/pdf-download/38619",previewPdfUrl:"/chapter/pdf-preview/38619",authors:[{id:"144252",title:"Dr.",name:"Gurjaipal",surname:"Kang",slug:"gurjaipal-kang",fullName:"Gurjaipal Kang"},{id:"155147",title:"Mr.",name:"Kevin",surname:"Kang",slug:"kevin-kang",fullName:"Kevin Kang"}],corrections:null},{id:"38617",title:"Giant Intracranial Aneurysms - Surgical Treatment, Accessory Techniques and Outcome",doi:"10.5772/46033",slug:"giant-intracranial-aneurysms-surgical-treatment-accessory-techniques-and-outcome",totalDownloads:2069,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Tomasz Szmuda and Pawel Sloniewski",downloadPdfUrl:"/chapter/pdf-download/38617",previewPdfUrl:"/chapter/pdf-preview/38617",authors:[{id:"142985",title:"PhD.",name:"Tomasz",surname:"Szmuda",slug:"tomasz-szmuda",fullName:"Tomasz Szmuda"},{id:"145482",title:"Prof.",name:"Pawel",surname:"Sloniewski",slug:"pawel-sloniewski",fullName:"Pawel Sloniewski"}],corrections:null},{id:"38628",title:"The Critical Care Management of Aneurysmal Subarachnoid Hemorrhage",doi:"10.5772/48474",slug:"the-critical-care-management-of-aneurysmal-subarachnoid-hemorrhage",totalDownloads:4044,totalCrossrefCites:0,totalDimensionsCites:2,hasAltmetrics:0,abstract:null,signatures:"Vishal N. Patel and Owen B. Samuels",downloadPdfUrl:"/chapter/pdf-download/38628",previewPdfUrl:"/chapter/pdf-preview/38628",authors:[{id:"143621",title:"Dr.",name:"Owen",surname:"Samuels",slug:"owen-samuels",fullName:"Owen Samuels"},{id:"144602",title:"Dr.",name:"Vishal",surname:"Patel",slug:"vishal-patel",fullName:"Vishal Patel"}],corrections:null},{id:"38632",title:"False Aneurysms",doi:"10.5772/48656",slug:"false-aneurysms",totalDownloads:2362,totalCrossrefCites:1,totalDimensionsCites:2,hasAltmetrics:0,abstract:null,signatures:"Igor Banzić, Lazar Davidović, Oliver Radmili, Igor Končar, Nikola Ilić and Miroslav Marković",downloadPdfUrl:"/chapter/pdf-download/38632",previewPdfUrl:"/chapter/pdf-preview/38632",authors:[{id:"144635",title:"Dr.",name:"Igor",surname:"Banzic",slug:"igor-banzic",fullName:"Igor Banzic"}],corrections:null},{id:"38623",title:"Marfan Syndrome - Advances in Diagnosis and Management",doi:"10.5772/48482",slug:"marfan-syndrome-advances-in-diagnosis-and-management",totalDownloads:2747,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:1,abstract:null,signatures:"Miguel Angel Ramirez-Marrero, Beatriz Perez-Villardon, Ricardo Vivancos-Delgado and Manuel de Mora-Martin",downloadPdfUrl:"/chapter/pdf-download/38623",previewPdfUrl:"/chapter/pdf-preview/38623",authors:[{id:"69989",title:"Mrs.",name:"Beatriz",surname:"Pérez-Villardón",slug:"beatriz-perez-villardon",fullName:"Beatriz Pérez-Villardón"},{id:"144788",title:"Dr.",name:"Miguel Angel",surname:"Ramirez-Marrero",slug:"miguel-angel-ramirez-marrero",fullName:"Miguel Angel Ramirez-Marrero"},{id:"148224",title:"Prof.",name:"Ricardo",surname:"Vivancos-Delgado",slug:"ricardo-vivancos-delgado",fullName:"Ricardo Vivancos-Delgado"},{id:"148225",title:"Dr.",name:"Manuel",surname:"De Mora-Martin",slug:"manuel-de-mora-martin",fullName:"Manuel De Mora-Martin"},{id:"155756",title:"Dr.",name:"Miguel Angel",surname:"Ramirez-Marrero",slug:"miguel-angel-ramirez-marrero",fullName:"Miguel Angel Ramirez-Marrero"}],corrections:null},{id:"38631",title:"Vascular Access for Hemodialysis",doi:"10.5772/48787",slug:"vascular_access_for_hemodialysis",totalDownloads:4677,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Ivica Maleta, Božidar Vujičić, Iva Mesaroš Devčić and Sanjin Rački",downloadPdfUrl:"/chapter/pdf-download/38631",previewPdfUrl:"/chapter/pdf-preview/38631",authors:[{id:"150188",title:"Dr.",name:"Bozidar",surname:"Vujicic",slug:"bozidar-vujicic",fullName:"Bozidar Vujicic"},{id:"154160",title:"Dr.",name:"Ivica",surname:"Maleta",slug:"ivica-maleta",fullName:"Ivica Maleta"},{id:"154161",title:"Dr.",name:"Iva",surname:"Mesaros Devcic",slug:"iva-mesaros-devcic",fullName:"Iva Mesaros Devcic"},{id:"154162",title:"Associate Prof.",name:"Sanjin",surname:"Racki",slug:"sanjin-racki",fullName:"Sanjin Racki"}],corrections:null},{id:"38621",title:"Atrial Septal Aneurysm",doi:"10.5772/48407",slug:"atrial-septal-aneurysm",totalDownloads:2189,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Soh Hosoba, Tohru Asai and Tomoaki Suzuki",downloadPdfUrl:"/chapter/pdf-download/38621",previewPdfUrl:"/chapter/pdf-preview/38621",authors:[{id:"143555",title:"Dr.",name:"Soh",surname:"Hosoba",slug:"soh-hosoba",fullName:"Soh Hosoba"},{id:"148452",title:"Prof.",name:"Tohru",surname:"Asai",slug:"tohru-asai",fullName:"Tohru Asai"},{id:"148453",title:"Dr.",name:"Tomoaki",surname:"Suzuki",slug:"tomoaki-suzuki",fullName:"Tomoaki Suzuki"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"5682",title:"Physiologic and Pathologic Angiogenesis",subtitle:"Signaling Mechanisms and Targeted Therapy",isOpenForSubmission:!1,hash:"847efcb8c059798ea2a963d9578de2f5",slug:"physiologic-and-pathologic-angiogenesis-signaling-mechanisms-and-targeted-therapy",bookSignature:"Dan Simionescu and Agneta Simionescu",coverURL:"https://cdn.intechopen.com/books/images_new/5682.jpg",editedByType:"Edited by",editors:[{id:"66196",title:"Dr.",name:"Dan",surname:"Simionescu",slug:"dan-simionescu",fullName:"Dan Simionescu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"950",title:"Cardiomyopathies",subtitle:"From Basic Research to Clinical Management",isOpenForSubmission:!1,hash:"c7d7b0f4e23517aad0ba9d2b3b71e544",slug:"cardiomyopathies-from-basic-research-to-clinical-management",bookSignature:"Josef Veselka",coverURL:"https://cdn.intechopen.com/books/images_new/950.jpg",editedByType:"Edited by",editors:[{id:"77776",title:"Prof.",name:"Josef",surname:"Veselka",slug:"josef-veselka",fullName:"Josef Veselka"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"940",title:"Atherogenesis",subtitle:null,isOpenForSubmission:!1,hash:"65accab87dc266373e16c0a9b1298a28",slug:"atherogenesis",bookSignature:"Sampath Parthasarathy",coverURL:"https://cdn.intechopen.com/books/images_new/940.jpg",editedByType:"Edited by",editors:[{id:"139179",title:"Dr.",name:"Sampath",surname:"Parthasarathy",slug:"sampath-parthasarathy",fullName:"Sampath Parthasarathy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"965",title:"Novel Strategies in Ischemic Heart Disease",subtitle:null,isOpenForSubmission:!1,hash:"4aacb23e8594bdc279097abdfcde0eb8",slug:"novel-strategies-in-ischemic-heart-disease",bookSignature:"Umashankar Lakshmanadoss",coverURL:"https://cdn.intechopen.com/books/images_new/965.jpg",editedByType:"Edited by",editors:[{id:"13913",title:"Dr.",name:"Umashankar",surname:"Lakshmanadoss",slug:"umashankar-lakshmanadoss",fullName:"Umashankar Lakshmanadoss"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"484",title:"Etiology, Pathogenesis and Pathophysiology of Aortic Aneurysms and Aneurysm Rupture",subtitle:null,isOpenForSubmission:!1,hash:"7474d0a284e963e957ff6d58739e244c",slug:"etiology-pathogenesis-and-pathophysiology-of-aortic-aneurysms-and-aneurysm-rupture",bookSignature:"Reinhart Grundmann",coverURL:"https://cdn.intechopen.com/books/images_new/484.jpg",editedByType:"Edited by",editors:[{id:"37604",title:"Prof.",name:"Reinhart",surname:"Grundmann",slug:"reinhart-grundmann",fullName:"Reinhart Grundmann"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4477",title:"Hypercholesterolemia",subtitle:null,isOpenForSubmission:!1,hash:"dae17abe1c80b18efb287a9a1d2bb64e",slug:"hypercholesterolemia",bookSignature:"Sekar Ashok Kumar",coverURL:"https://cdn.intechopen.com/books/images_new/4477.jpg",editedByType:"Edited by",editors:[{id:"170928",title:"Dr.",name:"Sekar",surname:"Ashok Kumar",slug:"sekar-ashok-kumar",fullName:"Sekar Ashok Kumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"222",title:"Diagnosis, Screening and Treatment of Abdominal, Thoracoabdominal and Thoracic Aortic Aneurysms",subtitle:null,isOpenForSubmission:!1,hash:"5414d5b88ca007aeb24487e703cf0351",slug:"diagnosis-screening-and-treatment-of-abdominal-thoracoabdominal-and-thoracic-aortic-aneurysms",bookSignature:"R.T. Grundmann",coverURL:"https://cdn.intechopen.com/books/images_new/222.jpg",editedByType:"Edited by",editors:[{id:"37604",title:"Prof.",name:"Reinhart",surname:"Grundmann",slug:"reinhart-grundmann",fullName:"Reinhart Grundmann"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1840",title:"The Cardiovascular System",subtitle:"Physiology, Diagnostics and Clinical Implications",isOpenForSubmission:!1,hash:"a6a573b1908e6bcab874e3f8bda10705",slug:"the-cardiovascular-system-physiology-diagnostics-and-clinical-implications",bookSignature:"David C. Gaze",coverURL:"https://cdn.intechopen.com/books/images_new/1840.jpg",editedByType:"Edited by",editors:[{id:"71983",title:"Dr.",name:"David C.",surname:"Gaze",slug:"david-c.-gaze",fullName:"David C. Gaze"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"955",title:"Congenital Heart Disease",subtitle:"Selected Aspects",isOpenForSubmission:!1,hash:"fbdf1e5d7a52527014f83610d02e4a86",slug:"congenital-heart-disease-selected-aspects",bookSignature:"P. Syamasundar Rao",coverURL:"https://cdn.intechopen.com/books/images_new/955.jpg",editedByType:"Edited by",editors:[{id:"68531",title:"Dr.",name:"P. Syamasundar",surname:"Rao",slug:"p.-syamasundar-rao",fullName:"P. Syamasundar Rao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2085",title:"Recent Advances in Cardiovascular Risk Factors",subtitle:null,isOpenForSubmission:!1,hash:"b23eb390ab06bf72371aa4947748d69a",slug:"recent-advances-in-cardiovascular-risk-factors",bookSignature:"Mehnaz Atiq",coverURL:"https://cdn.intechopen.com/books/images_new/2085.jpg",editedByType:"Edited by",editors:[{id:"37958",title:"Prof.",name:"Mehnaz",surname:"Atiq",slug:"mehnaz-atiq",fullName:"Mehnaz Atiq"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"66063",slug:"corrigendum-to-introductory-chapter-historical-perspective-and-brief-overview-of-insulin",title:"Corrigendum to: Introductory Chapter: Historical Perspective and Brief Overview of Insulin",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/66063.pdf",downloadPdfUrl:"/chapter/pdf-download/66063",previewPdfUrl:"/chapter/pdf-preview/66063",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/66063",risUrl:"/chapter/ris/66063",chapter:{id:"63640",slug:"introductory-chapter-historical-perspective-and-brief-overview-of-insulin",signatures:"Gaffar Sarwar Zaman",dateSubmitted:"June 29th 2018",dateReviewed:"August 28th 2018",datePrePublished:"November 5th 2018",datePublished:"February 6th 2019",book:{id:"6675",title:"Ultimate Guide to Insulin",subtitle:null,fullTitle:"Ultimate Guide to Insulin",slug:"ultimate-guide-to-insulin",publishedDate:"February 6th 2019",bookSignature:"Gaffar Zaman",coverURL:"https://cdn.intechopen.com/books/images_new/6675.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",slug:"gaffar-zaman",fullName:"Gaffar Zaman"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",fullName:"Gaffar Zaman",slug:"gaffar-zaman",email:"gffrzaman@gmail.com",position:null,institution:null}]}},chapter:{id:"63640",slug:"introductory-chapter-historical-perspective-and-brief-overview-of-insulin",signatures:"Gaffar Sarwar Zaman",dateSubmitted:"June 29th 2018",dateReviewed:"August 28th 2018",datePrePublished:"November 5th 2018",datePublished:"February 6th 2019",book:{id:"6675",title:"Ultimate Guide to Insulin",subtitle:null,fullTitle:"Ultimate Guide to Insulin",slug:"ultimate-guide-to-insulin",publishedDate:"February 6th 2019",bookSignature:"Gaffar Zaman",coverURL:"https://cdn.intechopen.com/books/images_new/6675.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",slug:"gaffar-zaman",fullName:"Gaffar Zaman"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",fullName:"Gaffar Zaman",slug:"gaffar-zaman",email:"gffrzaman@gmail.com",position:null,institution:null}]},book:{id:"6675",title:"Ultimate Guide to Insulin",subtitle:null,fullTitle:"Ultimate Guide to Insulin",slug:"ultimate-guide-to-insulin",publishedDate:"February 6th 2019",bookSignature:"Gaffar Zaman",coverURL:"https://cdn.intechopen.com/books/images_new/6675.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"203015",title:"Dr.",name:"Gaffar",middleName:"Sarwar",surname:"Zaman",slug:"gaffar-zaman",fullName:"Gaffar Zaman"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11569",leadTitle:null,title:"Bacterial Sexually Transmitted Infections - New Findings, Diagnosis, Treatment, and Prevention",subtitle:null,reviewType:"peer-reviewed",abstract:"
\r\n\tSexually transmitted infections (STIs) are a major concern for the public health system worldwide. These infections of the human reproductive system spread primarily through person-to-person contact and can be produced by a wide variety of pathogens. The most common bacteria involved in STIs are Chlamydia trachomatis, Neisseria gonorrhoeae, and mycoplasma. As most STIs are asymptomatic at debut, their clinical documentation is difficult. Lack of proper treatment can lead to serious complications such as chronic pelvic pain, infertility, pregnancy complications, pelvic inflammatory disease, an infection and inflammation of the uterus, fallopian tubes, and/or ovaries in women whose result may be permanent damage to a woman’s reproductive organs. It is documented that screening and treatment of bacterial vaginosis have increased the pregnancy rate considerably. Also, these infections may be transmitted from mother to newborn babies. It is known that these bacteria are very difficult to isolate on culture media by classical methods, therefore an accurate diagnosis of bacterial STI is difficult to be made in genitourinary infections. In recent years, however, nucleic acid amplification tests (NAATs) allowed their precise identification from different biological samples. Complications of STIs can cause similar symptoms in several pathogens, but antibiotic treatment may vary. On the other hand, the treatment is quite difficult due to the emergence of strains resistant to the antimicrobial agents used.
\r\n\r\n\tThis book aims to provide information on bacteria involved in STIs and their consequences due to lack of appropriate treatment, highlighting the importance of population-wide bacterial STI screening and implementation of prevention methods to reduce the spreading of these diseases in the population, especially in areas of high STI prevalence, providing useful information for practitioners or researchers interested in this topic.
",isbn:"978-1-80356-750-1",printIsbn:"978-1-80356-749-5",pdfIsbn:"978-1-80356-751-8",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,isSalesforceBook:!1,hash:"069d6142ecb0d46d14920102d48c0e9d",bookSignature:"Dr. Mihaela Laura Vica",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11569.jpg",keywords:"Bacterial Vaginosis, Pelvic Inflammatory Diseases, Detection, Treatment, Physical Findings, Traditional Methods, Molecular Assays, Etiology, Sexually Transmitted Pathogens, Antimicrobial Agents, Antibiotic Resistance, Mutations",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"March 25th 2022",dateEndSecondStepPublish:"May 31st 2022",dateEndThirdStepPublish:"July 30th 2022",dateEndFourthStepPublish:"October 18th 2022",dateEndFifthStepPublish:"December 17th 2022",remainingDaysToSecondStep:"8 days",secondStepPassed:!1,currentStepOfPublishingProcess:2,editedByType:null,kuFlag:!1,biosketch:"A researcher in molecular biology and microbiology, with over 70 publications, with more than 20 years of experience in laboratory work, member of the Romanian Society for Cell Biology, affiliated to the European Cell Biology Organisation, and the Cluj Society of Forensic Medicine.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"189561",title:"Dr.",name:"Mihaela Laura",middleName:null,surname:"Vica",slug:"mihaela-laura-vica",fullName:"Mihaela Laura Vica",profilePictureURL:"https://mts.intechopen.com/storage/users/189561/images/system/189561.JPG",biography:"She graduated from the “Babeş-Bolyai” University in Cluj-Napoca, Romania, Faculty of Biology. She has a Master\\'s Degree in Cellular Biology at the “Babeş-Bolyai” University and a Ph.D. in Medicine at the “Iuliu Haţieganu” University of Medicine and Pharmacy in Cluj-Napoca. Since 2013 she held research and teaching positions in the Cell and Molecular Biology Department at the University of Medicine and Pharmacy in Cluj-Napoca. Since 2006 she was involved in scientific research activities, with over 30 participations in national and international conferences where she has received 5 awards. She has published 2 books, 2 book chapters, and 44 research papers in international journals. She is a member of the Romanian Society for Cell Biology affiliated with the European Cell Biology Organisation. Her areas of research are microbiology and molecular biology.",institutionString:"‘Iuliu Haţieganu’ University of Medicine and Pharmacy",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Iuliu Hațieganu University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"16",title:"Medicine",slug:"medicine"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"280415",firstName:"Josip",lastName:"Knapic",middleName:null,title:"Mr.",imageUrl:"https://mts.intechopen.com/storage/users/280415/images/8050_n.jpg",email:"josip@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copy-editing and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6550",title:"Cohort Studies in Health Sciences",subtitle:null,isOpenForSubmission:!1,hash:"01df5aba4fff1a84b37a2fdafa809660",slug:"cohort-studies-in-health-sciences",bookSignature:"R. Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/6550.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9500",title:"Recent Advances in Bone Tumours and Osteoarthritis",subtitle:null,isOpenForSubmission:!1,hash:"ea4ec0d6ee01b88e264178886e3210ed",slug:"recent-advances-in-bone-tumours-and-osteoarthritis",bookSignature:"Hiran Amarasekera",coverURL:"https://cdn.intechopen.com/books/images_new/9500.jpg",editedByType:"Edited by",editors:[{id:"67634",title:"Dr.",name:"Hiran",surname:"Amarasekera",slug:"hiran-amarasekera",fullName:"Hiran Amarasekera"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"40793",title:"Identification of Polymorphism in the Keratin Genes (KAP3.2, KAP6.1, KAP7, KAP8) and Microsatellite BfMS in Merino Sheep Using Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) Analysi",doi:"10.5772/45762",slug:"identification-of-polymorphism-in-the-keratin-genes-kap3-2-kap6-1-kap7-kap8-and-microsatellite-bfms-",body:'Wool production is a major agricultural industry world-wide, the most important wool-growing countries include Australia, China, New Zealand, South Africa and countries within South America. In Australia for example, the world\'s largest producer of wool accounting for ~ 30% of the world production, wool industry is among the top industries in export revenue. While Australia has long been associated with the production of high-quality wool, the importance of this industry and the value of wool exports have been steadily declining.
The wool industry is faced with many challenges that require innovative solutions. The major competitors to the wool industry, cotton and synthetics, have developed new fibres that meet consumer needs such as being lightweight, soft and easy to care. These competitors have also made better productivity gains than wool, which has resulted in lower prices for all textile products. Today, there is much instability in wool prices, with a major problem facing the industry in faulty wool production. It has been observed that considerable variation exists both within and between fleeces across sheep breeds, as well as within inbred lines of sheep. Since the efficiency of wool processing is dependent on the consistency of wool fibre, it is of prime importance to wool producers that this variation is controlled. The wool characteristics that are of economic importance include fibre diameter (or fineness), grease and clean fleece weight, fleece strength and length, colour, yield, crimp and bulk. For Merino and halfbred wools, fibre diameter is the major factor that contributes to price variation as it significantly influences both fibre processing properties and ultimate product quality. The colour of wool is also important because superior colour (bright and white) can be dyed to the maximum range of shades and consequently is worth more than poorer coloured wool. Furthermore, the quantity of wool is important in overall wool production and in the efficiency of the production system.
For many years, farmers have been using classical selective breeding, where by selection of breeding animals was traditionally based on the phenotype (that is appearance) of the individual animal, a rather slow method of selection. Each animal is assigned a breeding value (BV), which describes the future genetic potential of an animal. The BV is calculated by adjusting phenotype to exclude factors such as birth rank, lambing status and sex in order to give an estimate of the genetic merit. The desired goal of this strategy is the accumulation of “good” forms of genes for that particular trait in the population, over time. This has resulted in many breeds that are commercially important today. The domestic sheep
The answer to sidestepping this “blind selection”, inaccuracy in describing the genetic potential of an animal and slow progress may lie in identifying specific genetic markers that are associated with wool production traits. Some sheep consistently produce quality or faulty wool, suggesting that genetic factors are an important key in determining wool characteristics. In addition, estimates for the heritability (h2) of most wool traits are generally high (h2 = 0.3 - 0.6), indicating that wool traits are under genetic control and that they can be selected for. A gene is a segment of DNA that provides the genetic information necessary to produce a protein. For almost all of the genes, there are two copies (alleles), one inherited from the mother and the other from the father. In any population of animals, there can be many different alleles. This is termed polymorphism or genetic variation. Polymorphism results from DNA mutation. It is this polymorphism that is taken advantage of, in order to identify genetic markers. A genetic marker for a particular characteristic can be defined as a piece of DNA that directly affects a phenotype and shows polymorphism. It can also be a piece of DNA that is closely linked to another piece of DNA that affects a phenotype. Genetic markers can either be genes or non-functional DNA segments such as microsatellites or minisatellites.
A number of different types of genetic markers are commonly used, including restriction fragment length polymorphisms (RFLPs), microsatellite and minisatellite DNA, and polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) variants. Restriction fragment length polymorphism results from the alteration of the restriction site(s) recognised by a specific restriction endonuclease or by the insertion or deletion of sequence between two restriction sites. The variation in fragment lengths is detected using gel electrophoresis. Although RFLPs were the first genetic markers developed, they are losing popularity as a screening method to identify genetic markers because they have the disadvantages of not identifying all of the polymorphism with a length of DNA, are time-consuming and restriction enzymes and consumables tend to be expensive. Simpler marker systems have subsequently been developed, many of these systems are now based on satellite DNA sequences.
Throughout the genome of higher eukaryotic organisms, there are a variety of different short DNA sequence repeats known as satellite DNA. These sequences do not code for protein and are highly variable from individual to individual in both the number and type of repeats (Groth et al., 1987). Microsatellites are composed of DNA repeats in tandem at each locus. The tandem repeats are usually simple, and consist of either a single nucleotide or dinucleotide such as (CA)n, with each dinucleotide repeated about ten times. Minisatellites have longer repeated sequences than microsatellites, such as (ACTG)n. Since microsatellites and minisatellites show a substantial amount of polymorphism, they can serve as useful markers for the identification of genetic variation of value to animal breeding. Although the variation in the number of repeats can sometimes be detected using RFLP, PCR is generally used to amplify the polymorphic region and the amplimer analysed for length variation (a technique referred to amplified fragment length polymorphism – AFLP).
PCR is also used in conjunction with SSCP. The PCR-SSCP technique offers a rapid, sensitive and relatively inexpensive way to screen for sequence variation with minimal sequencing. First described by Orita et al. (1989), this technique has become one of the preferred methods for screening samples to detect polymorphism because it is both simple and sensitive. In this techniques, regions of the gene of interest are amplified using PCR and the products denatured and then cooled rapidly to promote the formation of secondary structures due to internal base-pairing, which are in turn sequence dependent (Orita et al., 1989). The folded single-stranded DNA molecules are separated by polyacrylamide gel electrophoresis under non-denaturing conditions. The folded secondary structures are affected by physical conditions such as temperature, percentage of polyacrylamide, ionic strength of the electrophoretic buffer, glycerol concentration (Spinardi et al., 1991), ratio of acrylamide to bis-acrylamide, run length and run voltage. This can be exploited when optimising an SSCP protocol so that maximum variation can be detected in a given section of DNA. Molecules that differ by even a single nucleotide may form different conformers under a given set of conditions and, upon electrophoresis in a non-denaturing polyacrylamide gel, migrate differently. Many methods for viewing the folded DNA conformers have been described. These include the radioactive labelling of primers followed by autoradiography (Orita et al., 1989), silver staining (Sanguinetti et al., 1994), ethidium bromide staining (Yap and McGee, 1993) and more recently the use of fluorescently labelled primers and fluorescent dyes.
There are several ways to identify genetic markers, but the two approaches most commonly used are the genome scanning or linkage analysis and the candidate gene approach. In the genome scan approach, the whole genome is searched to identify Quantitative Trait Loci (QTL) that affect any given trait. These are not necessarily the genes that are responsible for trait variation, but give an indication of where such genes may lie. Linkage analysis is an involved process. A map of the chromosomes, laying out the location, phase and order of genes and markers, and the distance between them, is required before linkage analysis can be performed. Firstly, a selection of about 200 markers distributed throughout the genome are genotyped, in the sire of the animals. Only the informative markers are genotyped in the progeny and each marker tested for suggestive linkage. Regions showing suggestive linkage are then studied by saturating the region with markers to identify those that are tightly linked. Phenotypic variation is then linked to the segregation of DNA markers within a population. Once the gene locus is identified by the tightly linked markers, the DNA can be sequenced. Linkage analysis can be an expensive and lengthy process requiring access to full chromosome libraries and arrays of markers.
In the candidate gene approach, known genes or gene markers that are thought to be responsible for the phenotypic variance of a trait are targeted for investigation. In this case, knowledge of the understanding of the genes that are likely to affect wool quality. The method requires a good knowledge of the physiological and biochemical processes of the gene product and can be a more direct method than the gene mapping approach, provided the right initial assumptions are made. One of the limitations of this approach is its “hit and miss” nature. A targeted gene may not be polymorphic in a population or genetic variation within the targeted gene may not affect the trait (Goddard, 2002). For the candidate gene approach to be useful, a quick and relatively inexpensive way to screen the target gene for polymorphism is essential.
The wool fibre is a complex structure composed primarily of proteins from the keratin family, which are the keratin intermediate-filament proteins (KRTs) and the keratin intermediate-filament associated proteins (KAPs). The KRTs form the skeletal structure of the wool fibre (microfibrils) and are embedded in a matrix of KAPs (Powell and Rogers, 1986), the different proteins being connected through disulphide cross-linkages (Powell, 1996). Therefore, genes that code for the KAPs and KRTs proteins are potential candidate genes in the identification of genetic markers associated with wool quality traits.
Half-sib analysis is a tool that allows genetic effects to be ascertained from field trials while controlling for environmental and management effects. Firstly, the gene being targeted must be polymorphic, with at least two alleles. A good sire is selected and mated to many ewes (at least 200 in number), that are selected at random from a range of environments, in order to maximize phenotypic variation in wool traits. The sire must be informative at each locus that is being investigated (i.e., the genotype of the sire must be heterozygous). If not, then the progeny does not get genotyped for those loci that the selected sire is homozygous. For those loci that the sire is heterozygous, the progeny born are genotyped soon after birth, and allowed to grow until their wool measurements can be taken at (12, 24 and 36 months of age). Suppose a sire has the genotype AB at the K33 locus, then all the progeny that have inherited the A allele from the sire are put in one group, and those that have inherited the B allele from the sire are put in another group. The means of the wool measurements from both groups are then compared. If the group of progeny that inherited the B allele from their sire are found to for example have a significantly stronger staple strength than those progeny that inherited the A allele from their sire, then this would give an indication that the K33 B allele might be associated with stronger staple strength.
Numerous studies have described variation within both the KAP and KRT genes, including the work of Rogers et al. (1994a); Parsons et al. (1994a; 1996); McLaren et al. (1997); Beh et al. (2001); Itenge-Mweza et al. (2007). There are some reports associating variation in the KRT and KAP genes with variation in wool traits. Parsons et al. (1994b) and Beh et al. (2001) reported associations between variation in KAPs and mean fibre diameter in Merino sheep, while Rogers et al. (1994b) reported association between staple strength in Romney sheep and the region spanning the KAP1.1/KAP1.3/K33 loci on ovine chromosome 11. Itenge et al. (2009; 2010) reported association between variation in the KAP1.1 gene with variation in yield. In one of the half-sib families studied, variation in the K33 gene was associated with variation in staple strength. Markers, other than the KRT and KAP genes associated with wool traits have also been reported and these, together with reported keratin gene markers are summarised in Table 1.1.
Gel electrophoresis is the process in which an electrical current is applied to a gel to separate large molecules such as nucleic acids, from a mixture of similar molecules, based on differences or how they react to the electrical current. The technique relies on the fact that
Potential genetic markers for wool quality traits reported by various researchers.
nucleic acids are negatively charged because of the phosphate groups on the phosphodiester backbone of the nucleic acid strands (Nicholl, 1994). Nucleic acid molecules will migrate from the negative (black) terminal to the positive (red) terminal if put in solution and an electric field is applied, due to the net negative charge in solution. The gel matrix adds a sieving effect so that particles can be characterized by both charge and size.
Agarose is a macromolecular substance that is derived from seaweed. It can be purified to a whitish granular powder which, when mixed with water and heated, can be left to set like a jelly. This is called a gel and it acts like a sieve for the DNA molecules. To separate DNA molecules that are different lengths, agarose is used to produce a molecular sieve. The speed that the DNA travels through the gel is inversely proportional to the size of the DNA. In other words, small DNA particles migrate faster than large DNA molecules, as they are less physically restrained by the gel matrix. The length of a piece of DNA can be determined by comparing it to a molecular weight ladder. Agarose gel electrophoresis can be affected by:
The percentage of agarose, which affects the sieving of the DNA molecules.
The voltage applied during the electrophoresis, which cause the DNA molecules to move.
Typically, 1000 – 50,000 bp can be separated by 0.3% agarose, and 300 – 6000 bp can be separated by 1.4% agarose, while base pairs less than 500 are better separated using polyacrylamide gel, with gel percentage between 10-20. The polyacrylamide gel electrophoresis works under non-denaturing conditions.
After the electrophoresis is complete, the molecules in the gel can be stained to make them visible. Ethidium bromide, silver, or coomassie blue dye may be used for this process. Other methods may also be used to visualize the separation of the mixture\'s components on the gel. If the analyte molecules fluoresce under ultraviolet light, a photograph can be taken of the gel under ultraviolet lighting conditions, often using a Gel Doc. A molecular weight marker (MM) is often included on the gel to give an indication of the fragment size.
An example of a gel photo. MM is the molecular marker. Lane 1 has 341 bp DNA, while lane 4 has 280bp DNA. Lane 2 is blank.
This paper discusses the identification of genetic variation in the KAP3.2, KAP6.1, KAP7, KAP8, KRT2.10 and BfMS loci in Merino sheep using polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) analysis. Polymorphism within these loci is likely to be in part responsible for the observed variation in wool characteristics and could result in the identification of gene markers to be used in gene marker-assisted selection programmes within the wool industry.
This study used two half-sib families referred to as Sire Line 1 (SL1) and Sire Line 2 (SL2). The SL1 half-sib was produced by mating a fine wool producer Merino ram to 150 Merino ewes, selected at random from a range of New Zealand environments, in order to maximise phenotypic variation in wool traits. In year one, the SL1 consisted of 131 pure New Zealand Merino lambs, with 128 of these surviving to the second shearing at 24 months. Following the second shearing the wether lambs and some of the ewe lambs were culled and only the remaining ewe lambs (n = 37) were shorn at 36 months of age. The SL2 half –sib consisted of 35 lambs (Merino x Romney ram x Merino ewes). Half-sib groups were kept as single flocks to minimise environmental variation between individual progeny and provide control. All lambs were tagged at birth to their dam and their gender and birth rank were recorded.
Mid-side wool samples were collected at 12, 24 and 36 months of age for SL1 and at 12 months of age for SL2. Except for greasy fleece weight (GFW) which was determined at shearing, wool measurements were performed by the New Zealand Wool Testing Authority Ltd (NZWTA), Napier, New Zealand according to International Wool Textile Organisation (IWTO) standards. Measurements included comfort factor or the percentage of fibres of diameter greater than 30 µm (F<30), mean fibre diameter (MFD, IWTO-12-03), fibre diameter standard deviation (FDSD, IWTO-12-03), coefficient of variation of fibre diameter (CVD, IWTO-12-03) and curvature, were all measured using a Sirolan™ Laserscan Fibre Diameter analyser while the mean staple length (MSL, IWTO-30) and mean staple strength (MSS, IWTO-30) of each sample was determined using Automatic tester for Length and Strength (ATLAS). The colour (MY-Z) and brightness (MB) of the wool was measured using a reflectance spectrophotometer, where the tristimulus values Y-Z indicate the yellowness of the wool and the tristiulus value Y represents the brightness of the wool. The yield of wool, the weight of clean wool after impurities such as vegetable matter have been removed, expressed as a percentage of greasy wool weight was mathematically derived for the wool base (IWTO-19) measurements. Once yield measurements were obtained from the NZWTA, clean fleece weight (CFW) was calculated as the product of GFW and yield.
Blood samples (containing DNA) were collected from the progeny and sires onto FTATM cards (Whatman, Middlesex, UK). These were stored at room temperature (See Figure 2.1). A small punch (1.2 mm in diameter) was taken from the blood on the FTATM cards using a Harris Micro Punch (Whatman International Ltd, UK) and put into a 200 μL tube. The DNA on the punches was isolated following a modified manufacturer’s protocol. 200 μL of FTATM reagent was added to each tube containing a 1.2 mm punch of FTATM paper, containing the sample DNA. The tubes were incubated at room temperature for 60 minutes. Each tube was vortexed three times for about five seconds at the start of the incubation, half-way through the incubation, and after the incubation period. The FTATM reagent was aspirated, and the cards were washed with 200 μL of TE buffer (1 M Tris and 0.5 M Na2EDTA) for two minutes. The TE buffer was aspirated and the tubes were left open, but covered with a tube holder and stored at 4 oC and used for the subsequent PCR reaction.
The PCR conditions for the loci that are described in the literature were initially used. However, re-optimisation was necessary for amplification in an i-Cycler PCR machine (Bio-Rad Laboratories Inc., Hercules, CA, USA). The PCR protocols were optimised by using a temperature gradient (to determine annealing temperature) coupled with a magnesium titration.
All the primer sequences used in the study were obtained from the literature (Table 2.1), and were synthesized by Invitrogen New Zealand Limited, Penrose, Auckland, New Zealand. PCR amplifications were performed in a reaction mixture containing ~ 50 ng of genomic DNA on a washed 1.2 mm punch of FTATM paper, 1× PCR reaction buffer with 1U Taq polymerase (Qiagen, GmBH, Hilden, Germany). Table 2.2 lists the total reaction volume used along with the specific dNTP, primer, magnesium, and Q concentrations for each locus.
Amplification consisted of 1 minute denaturation at 95 oC, followed by 30 cycles of denaturation at 95 oC for 1 minute, annealing at temperatures specified in Table 2.3 for 1 minute and extension at 72 oC for 1 minute, with a final extension of 72 oC for 7 minute. All the primer sequences used in the study were obtained from the literature, and were synthesised by Invitrogen New Zealand Limited, Penrose, Auckland, New Zealand.
FTATM cards of blood samples collected from the progeny of sire line 1
Primer sequences and source references for each locus investigated.
Conce- tration (×) | |||||
KAP3.2 | 25 | 350 | 175 | 1.0 | 1× |
KAP6.1 | 25 | 400 | 200 | 1.0 | 1× |
KAP7 | 25 | 350 | 175 | 1.0 | 1× |
KAP8 | 25 | 350 | 175 | 1.0 | 1× |
KRT2.10 | 20 | 400 | 200 | 1.0 | - |
BfMS | 25 | 350 | 175 | 1.0 | 1× |
Optimised PCR conditions for each locus investigated.
KAP3.2 | 58 | 424 |
KAP6.1 | 62 | 528 |
KAP7 | 63 | 413 |
KAP8 | 62 | 124* |
KRT2.10 | 65 | 191 |
BfMS | 58 | 200* |
Optimised annealing temperatures and predicted amplimer sizes for each locus investigated.
Amplimers were analysed in 1.0% w/v SeaKem® LE agarose (FMC Bioproducts, Rockland, Maine, USA) gels prepared with 1× TBE buffer (89 mMTris, 89 mM orthoboric acid, 2 mM Na2EDTA; pH 8) containing 0.1 mg/L ethidium bromide. Five µL of PCR product was added to 2.5 µL of loading dye (0.2% bromophenol blue, 0.2% xylene cyanol, 40% (w/v) sucrose) and the gels were electrophoresed at a constant 10 Vcm-1 for 30 minutes. A molecular weight marker (Invitrogen Life Technologies) was included on the gel to give an indication of the fragment size. DNA bands were viewed on a UV transilluminator (254 nm) and a photograph taken for records.
PCR-SSCP conditions were available in the literature for KAP3.2 (McLaren et al., 1997), however these were deemed to be insufficiently stringent. For this reason, the PCR-SSCP protocols used in this study were established empirically using template DNA from two small half-sib families (to observe inheritance of allele-specific banding pattern) and DNA samples of other unrelated Merino sheep (for increased genotypic variation). Many different gel conditions (gel percentage, voltage, time of running, temperature, addition of glycerol) were assessed to determine the optimum combination of conditions to resolve allele specific banding patterns in a reproducible manner. Amplimers from sires of the SL1 and SL2 and their selected progeny were also included on the optimising gels in order to ascertain allele banding patterns by following inheritance, and to determine whether the sires were heterozygous, and therefore informative, for the locus genotyped. Alleles were named in the order they were identified using letters of the alphabet.
Each locus used specific SSCP gel conditions, and these are summarised in Table 2.4. Polyacrylamide (37.5:1 acrylamide / bis-acrylamide, Bio-Rad Laboratories, Hercules, Ca, USA) vertical gels (Protean II 16 x 16 cm, 1.0 mm thick spacers, 28 well comb, Hoefer, Inc., San Francisco, Ca, USA) were prepared containing 0.5× TBE (44.5 mMTris, 44.5 mM orthoboric acid, 1 mM Na2EDTA [pH 8.0]) and polymerised using 10% ammonium persulphate and TEMED. Gels were pre-electrophoresed at running temperatures and voltage for one hour. Amplimers were mixed with 50 µL loading dye (95% formamide, 10 mM Na2EDTA, 0.025% bromophenol blue, 0.025% xylene cyanol), denatured by heating at 95 oC for five minutes and immediately placed on wet ice before loading 15 µL aliquots. The gels were then electrophoresed at the optimum gel conditions with 0.5× TBE running buffer, followed by silver-staining according to the method of Sanguinetti et al. (1994).
For KAP3.2, KAP7 and KRT2.10 loci, genomic DNA was obtained from the sire and this DNA was amplified using the PCR conditions described above and the amplimers were subsequently cloned using the Promega pGEM® - T Easy Vector System I (Promega Corporation, Madison, WI, USA). Since each plasmid can only accept one molecule of DNA and therefore only one allele. Ligation reactions were performed in a total reaction volume of 10 μL containing three units T4 DNA ligase, 50 ng of plasmid DNA and 1× ligation buffer, and incubated overnight at 4 oC. Constructs were transformed into competent
KAP3.2 | 8 | 17 | 30 | 250 |
KAP7 | 10 | 4 | 20 | 200 |
KAP8 | 10 | 4 | 20 | 200 |
BfMS | 12 | 7 | 15 | 300 |
Optimised SSCP conditions for the loci investigated.
Plasmid standards were sequenced in the forward and reverse directions using the M13 forward and reverse primers at the Waikato University DNA Sequencing Facility, University of Waikato, New Zealand or Lincoln University Sequencing Facility, Lincoln, New Zealand. The sequences were compiled using DNAMANTM version 4.0 (Lynnon Biosoft, Quebec, Canada) and the electropherograms. To minimise the likelihood of PCR and sequencing errors, sequence data was derived from four separate colonies, at least two of which were from independent PCR amplifications. When sequencing data was consistent, the sequences were submitted to NCBI GenBank (http://www.ncbi.nlm.hih.gov). These were
In order for any of the loci to be informative, they have to be heterozygous in the chosen sires allowing the segregation of the sire alleles to be followed in the progeny and segregation analyses performed. Segregation of the sire alleles within SL2 was observed and a chi-square goodness of fit test performed to ascertain whether the sire alleles inherited by the progeny occurred in a 1:1 ratio within the population. Any progeny which had the same genotype as both its sire and dam was excluded from the association analysis since it was not possible to determine which of the alleles had been inherited from the sire. The association of alleles of KAP8 with all measured wool traits (MFD, FDSD, CVD, curvature, yield, yellowness, brightness, comfort factor, staple length, staple strength, GFW and CFW) was then analysed for each year of phenotypic data using an analysis of variance (ANOVA) tests using SPSS version 13 (SPSS Science Inc., Chicago, IL, USA). The ANOVA model included sire allele and gender as factors and a full factorial model was used. The analysis used assumed that the ewe’s alleles effects were distributed randomly in progeny. The date of birth was not included in the ANOVA because the progeny were half-sibs born in a five weeks period, and it was assumed that variation in birth date was balanced across the half-sib in the segregation analyses, and that none of the genes analysed had a significant effect on gestation length.
Six loci (KAP3.2, KAP6.1, KAP7, KAP8, KRT2.10 and BfMS) were included in the study. All of them were amplified successfully using PCR and polymorphism was detected in three loci (KAP3.2, KAP8 and BfMS). Of the loci which were polymorphic, only KAP8 was heterozygous for SL2 (Tables 3.1), and thus potentially informative as a genetic marker. The remaining loci appeared to be homozygous in the sires, and thus uninformative. Table 3.2 shows the genotype of SL2 progeny at KAP8 locus.
No. of alleles detected | SL1 genotype | SL2 genotype | Informative1 (Yes / No) | |
KAP3.2 | 3 | AA | AA | No |
KAP6.1 | 1 | AA | AA | No |
KAP7 | 1 | AA | AA | No |
KAP8 | 4 | AA | AB | Yes2 |
KRT2.10 | 1 | AA | AA | No |
BfMS | 3 | AA | CC | No |
Genotype results for the loci investigated in the study, indicating whether the sire genotype was informative (heterozygous) or non-informative (homozygous).
Lamb genotype | ||
1027 | 86 | AB |
1028 | 162 | AA |
1029 | 57 | BB |
1030 | 114 | AA |
1031 | 59 | AB |
1032 | 59 | AA |
1033 | 105 | AA |
1034 | 89 | AA |
1035 | 51 | AB |
1036 | 49 | AD |
1037 | 120 | AA |
1038 | 56 | AB |
1039 | 65 | AC |
1040 | 47 | AB |
1041 | 119 | BB |
1045 | 77 | BB |
1046 | 155 | AA |
1048 | 14 | BB |
1049 | 130 | AA |
1050 | 161 | AA |
1051 | 84 | BB |
1052 | 150 | BB |
1053 | 17 | BB |
1054 | NT | AA |
1055 | 113 | AB |
1056 | 140 | BB |
1057 | 21 | AB |
1058 | 87 | AA |
1059 | 135 | AB |
1060 | 137 | AA |
1061 | 117 | AC |
1062 | 38 | AB |
1063 | 148 | AB |
1064 | 68 | AB |
1065 | . | ? |
1067 | 116 | AA |
1068 | 58 | ? |
1069 | 64 | AA |
Genotype of KAP8 SL2 progeny
Four banding patterns were identified for the KAP8 microsatellite amplimer using PCR- SSCP typing methods, and these were named A, B, C and D (Figure 3.1). The alleles were not sequenced. Mendelian inheritance was observed in SL2 half-sib family for KAP8 (Table 3.2). A Chi-square goodness of fit analysis to test whether the segregation of the sire alleles differed from a 1:1 ratio confirmed normal Mendelian segregation (Table 3.3).
PCR-SSCP of the 124 bp amplimer of the KAP8 microsatellite showing the four alleles identified. Amplimers were electrophoresed on a 10% non-denaturing acrylamide/bis-acrylamide gel for 4 hours, 200 V at room temperature (20 oC). Genotype of an individual animal is shown below each lane. SL2 genotype (AB) is bolded, and his randomly selected half-sib progeny are shown in italics.
SL2 Genotype | AB |
Number of progeny inheriting allele A | 17 |
Number of progeny inheriting allele B | 12 |
Number of progeny genotyped same as the sire | 5 |
Total number (n) | 34 |
χ2 | 0.8621 |
P-value1 | 0.3532 |
Segregation of sire alleles within SL2 sire-line. Chi-square goodness of fit was used for to ascertain whether the sire alleles inherited by the progeny occurred in a 1:1 ratio within the population. Probability values (
SL1 was homozygous at the KAP8 locus based on SSCP gel patterns, and hence uninformative. SL2 was heterozygous at the KAP8 locus, having the genotype AB. Eleven out of 36 progeny had the genotype AB (Table 3.2), which was the same as that of the sire. The genotype of the ewes for these lambs was subsequently determined. Five of the ewes genotyped as AB, and the progeny of these ewes were excluded from further statistical analysis as the allelic contribution from the sire could not be determined.
The sire alleles at the KAP8 locus showed a Mendelian pattern of inheritance and segregated in a 1:1 ratio in the progeny of each half sib (Table 3.3). Statistical analyses within sire SL2 half-sib family showed that there were no association between the sire alleles (or gender) and variation of wool traits.
The number of differences between alleles within sire-lines which were not statistically significant suggested the possibility of Type II errors (failing to detect a difference when in fact there is one). To address this issue, a power analysis was conducted for each trait within each of the sire-lines to determine whether the sample sizes available were adequate to detect at least 10% differences between alleles, within each sire-line, at P<0.05 with 80% power, i.e. nper allele= (8 × 2 × Error Mean Squareestimate)/(0.1 × trait averageacross sire-lines)2.
This equation was then rearranged to allowed the actual detectable difference to be calculated for each sire-line, i.e. % detectable difference = [
KAP3.2 and BfMS were found to be polymorphic in the progeny used in this study, although they appeared to be homozygous for both sires used (Figures 3.2 and 3.3, respectively). This was confirmed with cloning and sequencing amplimers derived from sire SL1.
29 | Prickle factor | 1.61 | 1.75 | 1080 | 2159 | |
29 | MFD | 19.07 | 10.57 | 46 | 93 | |
29 | FDSD | 3.89 | 67.23 | 7103 | 14207 | |
29 | CVD | 20.46 | 91.34 | 349 | 698 | |
29 | Curvature | 94.58 | 0.45 | 0 | 0 | |
29 | Yield | 71.84 | 9.79 | 3 | 6 | |
29 | Staple length | 73.33 | 2.04 | 1 | 1 | |
29 | Staple strength | 31.30 | 12.58 | 21 | 41 | |
29 | Brightness | 69.92 | 0.27 | 0 | 0 | |
29 | Yellowness | -2.83 | 135.71 | 27195 | 54389 |
Sample size required to detect at least a 10% difference between KAP8 sire allele groups in the wool traits list for each sire-line, at P<0.05 with 80% power.
29 | 12 | Prickle factor | 1.77 | 86.3 | 29.5 | |
29 | 12 | MFD | 19.21 | 17.9 | 3.2 | |
29 | 12 | FDSD | 3.91 | 221.3 | 1.9 | |
29 | 12 | CVD | 20.45 | 49.1 | -0.4 | |
29 | 12 | Curvature | 97.04 | 0.7 | 6.4 | |
29 | 12 | Yield | 72.69 | 4.6 | 1.1 | |
29 | 12 | Staple length | 33.56 | 2.0 | 4.3 | |
29 | 12 | Staple strength | 69.06 | 11.9 | 22.6 | |
29 | 12 | Brightness | -2.97 | 0.8 | -2.1 | |
29 | 12 | Yellowness | 72.60 | -433.1 | 7.1 |
A comparison of the smallest detectable difference between KAP8 sire-allele groups with the progeny numbers used and the observed difference between the sire-allele groups means for each wool trait measured.
Polymorphism could not be detected at the KAP6.1, KAP7 and KRT2.10 loci in any of the animals used in this study. KAP 7 was sequenced, and nucleotide sequences from SL1 KAP7 amplimer (GenBank accession number AY791846) was aligned with the published KAP7 gene by Kuczek and Rogers (1987); GenBank accession number X05638) which shows two unique sequences (Figure 3.4).
PCR-SSCP analysis of the 424 bp amplimer of the KAP3.2 gene showing the three alleles identified (A, B and C). The genotype of an individual animal is shown below each lane.
PCR-SSCP analysis of the 200 bp amplimer of the BfMS microsatellite showing the three alleles identified (A, B and C) using a half-sib test family. The genotype of an individual animal is shown below each lane. Sires SL1 and SL2 genotypes are bolded.
Alignment of the KAP7 gene sequence cloned from sire MV144-58-00 (Accession number AY791846) with
Sex Average (cM) | |||||
101.9 | 84.3 | 119.3 | \\BM4129 | Sequence – tagged site | |
104.1 | 86.6 | 122.0 | \\UCDO31 | RAPD Marker | |
107.1 | 89.0 | 125.2 | \\MCM58 | Microsatellite | |
111.3 | 91.7 | 130.5 | \\BL41 | VANGL1 | |
111.3 | 91.7 | 132.2 | \\BM723 | STS | |
111.3 | 91.7 | 132.2 | \\BM723 | STS | |
113.8 | 92.9 | 133.9 | \\OARAE57 | Microsatellite | |
123.4 | 105.2 | 142.2 | \\MCMA6 | ? | |
124.5 | 106.8 | 142.2 | \\MCMA6L | ? | |
124.5 | 106.8 | 142.2 | \\BMS482 | Sequence – tagged site | |
124.5 | 106.8 | 142.2 | \\CSSM054 | Phosphoglycerate dehydrogenase | |
126.0 | 107.9 | 143.2 | PRPF3 protein | ||
126.0 | 108.9 | 143.2 | Aryl hydrocarbon receptor nuclear translocator | ||
126.0 | 108.9 | 143.2 | Trichohyalin | ||
127.3 | 111.1 | 144.3 | \\RM065 | Dinucleotide repeat | |
132.0 | 115.3 | 149.1 | ~CSAP033E | Microsatellite | |
134.9 | 120.0 | 150.4 | Immunoglobulin superfamily 9 | ||
135.7 | 121.5 | 150.4 | ATPase | ||
137.0 | 121.5 | 152.9 | ADAM metallopeptidase | ||
139.8 | 122.7 | 156.8 | \\URB006 | Sequence – tagged site | |
143.6 | 127.6 | 160.4 | \\BM6438 | Sequence – tagged site | |
143.6 | 127.6 | 160.4 | Oligodendrocyte transcription factor 2 | ||
144.8 | 127.6 | 162.2 | \\SRCRS23H | ? | |
144.8 | 127.6 | 162.2 | \\TGLA49 | Microsatellite | |
144.8 | 127.6 | 162.2 | \\DVEPC88 | Neu associated kinase | |
145.3 | 127.6 | 163.1 | Keratin associated protein 7.1 | ||
145.3 | 127.6 | 163.1 | Keratin associated protein 7.1 | ||
145.3 | 127.6 | 163.1 | Keratin associated protein 8.1 | ||
145.3 | 127.6 | 163.1 | Keratin associated protein 7.1 | ||
145.3 | 127.6 | 163.1 | Keratin associated protein 11.1 | ||
145.4 | 127.6 | 163.2 | Keratin associated protein 6.1 | ||
145.8 | 127.6 | 164.0 | Glutamate receptor, ionotropic, kainite 1 | ||
149.6 | 131.5 | 168.1 | Amyloid beta (A4) precursor protein | ||
150.5 | 131.5 | 169.5 | \\BMS574 | Sequence – tagged site | |
150.5 | 131.5 | 170.2 | \\DVEPC117 | Sequence – tagged site | |
150.5 | 131.5 | 170.2 | \\DVEPC117 | Sequence – tagged site | |
152.1 | 132.8 | 171.3 | \\BMS2321 | Sequence – tagged site | |
153.2 | 132.8 | 173.1 | \\DVEPC128 | Neural cell adhesion molecule 2 | |
157.1 | 138.0 | 176.7 | \\RM095 | Dinucleotide repeat | |
158.1 | 138.0 | 177.6 | \\MAF64 | Dinucleotide repeat | |
169.2 | 150.1 | 188.2 | \\ILSTS004 | Sequence – tagged site | |
171.1 | 152.6 | 188.2 | \\DVEPC54 | Microsatellite | |
174.4 | 154.8 | 194.2 | \\MCMA8 | Sequence – tagged site | |
176.0 | 154.8 | 197.2 | \\MNS94 | Microsatellite | |
193.1 | 169.9 | 216.0 | \\CSSM004 | Microsatellite | |
195.3 | 171.1 | 219.6 | \\BMS4000 | Sequence – tagged site | |
200.0 | 177.1 | 223.6 | \\UCDO46 | ? |
Linkage map for part of ovine chromosome 1 (modified from http://rubens.its.unimelb.edu.au/~jillm/jill.htm). The bolded genetic markers were investigated in this study.
(cM) | Female (cM) | Male (cM) | |||
149.6 | 151.4 | 148.8 | \\BMS695 | Sequence – tagged site | |
149.6 | 151.4 | 148.8 | \\BM827 | Microsatellite | |
152.5 | 151.4 | 153.4 | \\MCM141 | ? | |
153.1 | 151.4 | 154.3 | \\OARSHP2 | Microsatellite | |
153.1 | 151.4 | 154.3 | \\ILSTS042 | Sequence – tagged site | |
154.1 | 151.4 | 156.3 | \\BMS424 | Sequence – tagged site | |
163.1 | 155.2 | 170.4 | \\BP1 | Blood pressure QTL1 | |
163.1 | 155.2 | 170.4 | \\DU469297 | ? | |
165.6 | 160.5 | 170.4 | \\EPCDV025 | ? | |
167.1 | 166.2 | 170.4 | KIT Ligand | ||
168.7 | 166.6 | 172.4 | \\UCDO13 | ? | |
170.7 | 166.6 | 174.3 | Keratocan | ||
170.7 | 166.6 | 174.3 | Lumican | ||
177.8 | 172.1 | 182.4 | \\AGLA293 | Microsatellite | |
179.4 | 174.9 | 183.5 | ~CSAP017E | Microsatellite | |
179.4 | 174.9 | 183.5 | \\OARFCB5 | Dinucleotide repeat | |
179.4 | 174.9 | 183.5 | Glycosylation dependant cell adhesion molecule | ||
179.4 | 174.9 | 183.5 | \\OARHH38 | Microsatellite | |
180.0 | 176.2 | 183.5 | \\ILSTS022 | Sequence – tagged site | |
180.0 | 176.2 | 183.5 | Retinoic acid receptor 8 | ||
182.9 | 178.7 | 186.5 | Keratin | ||
183.9 | 181.2 | 186.5 | Keratin | ||
183.9 | 181.2 | 186.5 | \\BMC1009 | Similar to intermediate filament type II keratin | |
186.3 | 181.2 | 190.9 | \\CABB011 | Genomic survey sequence | |
188.2 | 185.3 | 190.9 | \\CSSM034 | Microsatellite | |
188.2 | 185.3 | 190.9 | Histone deacetylase 7A | ||
188.2 | 185.3 | 190.9 | \\UCDO52 | ? | |
195.5 | 188.6 | 201.0 | \\BL4 | Bell-like homeodomain protein 4 | |
197.0 | 190.4 | 202.8 | Lysozyme | ||
198.6 | 191.8 | 204.6 | \\CSRD2125 | ? | |
199.1 | 191.8 | 205.5 | Interferon gamma | ||
199.1 | 191.8 | 205.5 | Interferon gamma | ||
199.1 | 191.8 | 205.5 | Interferon gamma | ||
202.2 | 195.4 | 207.8 | \\BMS1617 | STS | |
204.1 | 196.7 | 210.6 | \\OARVH34 | Microsatellite | |
206.2 | 197.7 | 213.7 | \\BR2936 | Sequence – tagged site | |
207.0 | 197.7 | 215.5 | \\OARVH130 | Microsatellite | |
207.0 | 197.7 | 215.5 | \\MAF23 | Microsatellite | |
209.0 | 199.0 | 218.1 | \\OARCP43 | Microsatellite | |
214.7 | 208.6 | 219.8 | \\RM154 | Tandem repeat region | |
218.5 | 211.3 | 223.7 | Insulin like growth factor | ||
218.5 | 211.3 | 223.7 | Insulin like growth factor | ||
218.5 | 211.3 | 223.7 | Insulin like growth factor | ||
218.5 | 211.3 | 223.7 | Insulin like growth factor | ||
223.9 | 215.4 | 231.6 | \\CSRD2111 | ? | |
224.4 | 215.4 | 232.5 | ~CSAP009E | ? |
Linkage map for part of ovine chromosome 3 (modified from http://rubens.its.unimelb.edu.au/~jillm/jill.htm). The bolded genetic markers were investigated in this study.
Four alleles, designated A, B, C and D were identified at the KAP8 (CA)n repeat microsatellite locus using PCR-SSCP in this study. The microsatellite at the KAP8 locus was included in the study because this region is highly polymorphic, with 15 alleles previously reported (Wood et al., 1992) using denaturing polyacrylamide gel electrophoresis, while Parsons et al. (1994a) detected four allelic fragments (123, 125, 133 and 139 bp) at the same locus using the methods by Wood et al. (1992) in a Merino half-sib family. Only SL2 was heterozygous at the KAP8 microsatellite in this study. SL1 was homozygous, despite the reported highly polymorphism in this locus (Wood et al., 1992). The method used to detect polymorphism in this study differed to that of (Wood et al., 1992), which used denaturing polyacrylamide gel electrophoresis. In this study, PCR-SSCP was used because this technique is simple, sensitive, relatively inexpensive and routinely used in the laboratory where the research was carried out. It is possible that if the original technique was employed, more alleles may have been observed at this locus.
Neither of the SL2 alleles were associated with variation in the wool traits that were measured (data not shown). The possibility of this locus having an affect on wool traits cannot be ruled out however, because only two alleles (that were the genotype of SL2) were analyzed, and that the sample numbers used in the study were relatively small (n = 29). Power analysis results (Table 9.5) showed that the observed differences between the sire allele groups were smaller than the smallest detectable difference for MFD, FDSD, CVD, curvature, yield, staple length, brightness and yellowness and therefore the possibility of making a Type II error (i.e. not detecting an association when there was one) is likely. Variation in MFD has previously been significantly associated with alleles at the KAP8 locus (Parson
Three alleles, designated A, B and C were identified at the KAP3.2 locus. However, both sire lines were homozygous, and thus uninformative. McLaren et al. (1997) identified two alleles at the KAP3.2 locus using PCR-SSCP methods. KAP3.2 (together with KAP1.1, KAP1.3 and K33) have been mapped to ovine chromosome 1 (Figure 3.5). Variations in all of the three genes (KAP1.1, KAP1.3 and K33) have been previously associated with variation in wool traits (Itenge et al., 2009; Itenge
Polymorphism could not be detected at the KAP6.1, KAP7 and KRT2.10 loci in this study, although all of these genes have been reported to be polymorphic in the literature (Parsons et al., 1993; McLaren et al., 1997). The reported polymorphism in KRT2.10 (two alleles) and KAP7 (four alleles) was identified using PCR-RFLP (McLaren et al., 1997) whereas the polymorphism within KAP6.1 (two alleles) was revealed with PCR-SSCP of
Loci that were polymorphic, but uninformative in this study (KAP3.2, BFMS) )need to be investigated further. Sires that are heterozygous at these loci need to be identified and used in half-sib analysis. Other loci that map to the same chromosome regions as the keratin genes investigated in this study are also worth of investigating in the future as potential gene markers for wool quality traits. On chromosome 1, future genes of interest include KAP11.1 and genes coding for trichohyalin (a very important wool follicle protein) (refer to Figure 3.5). On chromosome 3, loci of interest include KRT2.13, BMC1009 (Similar to intermediate filament type II keratin), RARG (Retinoic acid receptor 8) and IGF1 (insulin like growth factor) (refer to Figure 3.6). It is worth noting that previous studies by Damak et al. (1996) have shown positive effects of IGF1 on wool traits. Transgenic sheep produced by pronuclear microinjection with a mouse ultra-high-sulphur keratin promoter linked to an ovine IGF1 resulted in significant increase of CFW and bulk in transgenic sheep compared to non-transgenics, although MFD did not show significant differences (Damak et al.,1996).
There are other genes that have not been positioned on the linkage map that may be potential gene markers for wool quality traits. Some of these have already been associated with wool quality traits. These include the retinoic acid receptor (RARα) (Nadeau et al., 1992), homeobox proteins (HOX2) (Nadeau et al., 1992) and growth hormone (Hediger et al., 1990). Retinoic acid induces expression of genes such as homeobox and KRTs and there is a possibility that retinoic acid is involved in the regulation of KAPs, given its genomic position on chromosome 11 (Parsons et al, 1994c). Growth hormone has been positioned on chromosome 11 through
The search for genetic markers affecting wool quality traits is very different to genetic engineering (GE) and transgenesis. While GE involves the manipulation or modification of genetic composition of an organism, and transgenesis requires the development and use of transgenic animals, the former detects changes within the genetic make-up of an organism, but does not alter it. Marker-assisted selection may therefore be better preferred within the wider “non-scientific” community, than the use of transgenic sheep to produce superior wool traits. Transgenesis in sheep is also still in its infancy, and successful transgenesis rates are very low (less than 13%) (Powell et al., 1994). This makes marker-assisted-selection a more efficient, relatively cheaper and easier technique to improve wool quality traits than sheep transgenesis. The debate on GE will most likely continue and intensify especially where animals are involved. However, marker-assisted technology in livestock offers a powerful "green" alternative to gene manipulation.
Genetic markers are not affected by environmental noise and would allow sheep breeders to select animals with improved wool characteristics at an early age and cull the non-desirable lambs. This would speed up the process of genetic selection and decrease the generation interval. There is therefore a potential to select superior animals very early in life and not have to wait for an animal to reach its adult life to demonstrate that it has superior wool quality. This has the advantage of overcoming the limitation of “blind” selection, and increase the accuracy and efficiency of selection and result in a more profitable wool industry with direct benefits of cost to the consumer.
I thank the Almighty God for everything in my life. I wish to thank my Honours supervisor, Prof. Jim Reynoldson from Murdoch University and my PhD supervisors (Prof. Jon G. H. Hickford from Lincoln University and Dr. Rachel Forrest from Eastern Institute of Technology). I am very grateful for the AUS-AID and NZAID scholarships that I received from the Australian and New Zealand governments, respectively. I am also very grateful for the Staff Development Fellowship award that I received from the University of Namibia.
Patients with rheumatoid arthritis (RA) present damaged joints and pain [1], low muscle strength values [2], and cachexia [3, 4], while post-menopausal women represent the greater percentage of these patients [5]. Otherwise, patients with RA [6] and post-menopausal women [7] also present an increased risk of fall. So, interventions aimed to reduce the risk and to prevent falls seem to be advisable for patients with RA, especially in the post-menopausal women group.
Falls have been associated with different identifiable risk factors [7, 8], which includes an unsteady gait [8] and an ineffective postural stability [9]. Gait and postural stability are dependent of motor control processes, assured by the central nervous system at different levels. According to literature, foot and ankle play a significant role to keep an effective postural stability in bipedal or unipedal activities [10], namely during gait [11, 12]. Furthermore, foot and ankle problems are associated with an increment of the risk of falls [13]. The control of the foot and ankle kinematics is especially important in the gait stance phase [14]. At gait stance phase, the ankle execute, in the sagittal plane, three different angular displacements, which were defined in prior studies as controlled plantar flexion, controlled dorsiflexion, and powered plantar flexion sub-phases [15, 16, 17]. These three angular displacements sub-phases are associated with the three objectives of foot control, mentioned in the literature [18, 19], that occurs in the gait stance phase: first, to control the impact on the ground; second, to control the foot as a stable limb; and third, to control the foot to propel the body. Consequently, ankle angular positions, ankle moment of force peak, and ankle power peak during stance phase have been reported as important biomechanical parameters for foot function measurement [20, 21]. Patients with RA have differences in ankle kinematics and kinetics during the gait stance phase, when compared with healthy controls, namely: at ankle angles [20, 21, 22, 23, 24]; lower ankle power peak [21, 22]; and lower ankle moment of force peak [21, 23, 24]. Moreover, previous studies [21, 24] correlated lower gait speeds – observed in these patients – with a reduced ankle moment of force peak and ankle power peak. According to the literature [23, 25], an impaired ankle power can reduce the capacity of adjustment and increment of gait speed, leading to a lower functional capacity. A subsequent study [14] specifically compared a group of post-menopausal women with RA with a group of age-matched healthy post-menopausal women. Data from this study showed that these patients yielded a lower ankle moment of force and a lower power performance during the powered plantar flexion sub-phase. The authors of this study concluded that it should be important to improve these kinetic values in post-menopausal women with RA, since they were vital concerning foot and ankle function, functional capacity, and fall prevention. According to the same study [14], post-menopausal women with RA also showed a higher stride-to-stride variability in the ankle moment of force peak. According to the literature, an increment of motor variability was also found in elders with history of falls [26, 27, 28], which could be a manifestation of an impaired motor control [29].
The nervous system, composed by the central nervous system and the peripheral nervous system, allows motor control during human movement. The central nervous system controls movement through three different levels (cerebral cortex, brain stem, and spinal cord), which are hierarchically organized, interdependent and connected between them: (1) the most complex voluntary movements are regulated by the cerebral cortex – upper level; (2) postural stability, as well as the automatic and stereotyped movements, are regulated by the brain stem – middle level; (3) movement is also regulated at the spinal cord – lower level [30, 31]. The peripheral nervous system enables the connection of the periphery with the middle and lower levels of the central nervous system [32]. Otherwise, the somatosensory information, composed by the mechanoreceptive, thermoreceptive, and nociceptive information arising from the periphery, also plays an important role in movement control [31]. Proprioception, a subcomponent of the somatosensory information, encompasses the afferent information arising from mechanoreceptors (located at the periphery) and contributes to joint and postural stability control [31]. This proprioceptive information is transmitted to the three levels of the central nervous system, providing an optimization of the motor control [33]. The reciprocal innervation, an essential mechanism of the spinal cord regulation of the movement, is dependent on the quality of proprioceptive information (e.g., information arising from neuromuscular spindle, Golgi tendon organ, and mechanoreceptors located in joints) [34]. Accordingly, the quality of the movement is reliant on proprioception, both at a global (postural) level and at a local (joint) level [33, 35]. Therefore, a specific exercise programme could be conducted specifically to challenge and improve proprioceptive mechanisms, enhancing motor control processes [36]. This kind of exercise, made with this goal, could achieve the denomination of proprioceptive exercise [37]. According to a systematic review [38], there is evidence that proprioceptive exercises programmes can lead to improvements in proprioception and somatosensory function, namely programmes lasting 6 or more weeks (longer programmes have a greater effect); however, authors also concluded that there was a great variability and lack of detail concerning the training parameters (e.g., weekly frequency and workout duration) defined in the selected studies, making impossible to know the optimal dose–response.
Several interventions to prevent falls in elderly (e.g., exercises programme, educational programme, medication optimisation, environmental modification, and multiple interventions) have been established and evaluated [39]. Exercise programmes can prevent falls in elderly, especially those that include “balance” exercises [40, 41]. “Balance”, “coordination”, and “postural” exercises were classified as proprioceptive exercises in previous studies [36, 42]. According to a previous study [43], the incidence of falls in elderly was reduced after a proprioceptive exercise program. Thus, exercise is a good contribution for preventing falls; however, proprioceptive exercises, with their specificity, contribute in a more decisive way, stimulating and enhancing motor control processes.
Patients with RA benefit from the safety of the aerobic training, strength training, and from combinations of both. This is evidenced in published systematic reviews and meta-analysis [44, 45, 46, 47]. Nonetheless, it was concluded in a prior systematic review [42] that there is a lack of studies that approach the safety and effectiveness of proprioceptive exercises regarding the improvement of functional capacity of these patients. Although these authors had not found any randomized or controlled clinical trial, a more recent systematic review [48] concluded that there is some evidence that, the so called, proprioceptive exercises are safe to apply in patients with RA and helpful in the increment of their functional capacity. In parallel, proprioceptive exercises programmes have revealed effective in elderly regarding improvements of their gait biomechanical parameters [49, 50, 51]. Exercise programmes are important to prevent falls [40, 41, 43], however, proprioceptive exercises programmes differs from others by its capacity to stimulate and enhance proprioception and somatosensory function [38]. However, it is noted that to the best of our knowledge, the effects of a proprioceptive exercises programme on gait biomechanical parameters were not studied in patients with RA. Furthermore, researches that evaluate the safety of this kind of exercises, in patients with RA, are also required.
The previous rational supported the twofold aim of the present study. First, it aimed to evaluate the effects of a proprioceptive exercises programme on disease activity of post-menopausal women with RA. Second, it also aimed to evaluate the effects on ankle kinematics and kinetics during the gait stance phase and on its variability.
To achieve the defined aims, a prospective, single-blind, controlled but non-randomized trial study was conducted. The study was concepted in respect of the Declaration of Helsinki [52] and approved by the Ethical Committee for Health of the Portuguese Institute of Rheumatology, Lisbon, Portugal.
The selected post-menopausal women with RA (n = 27) were recruited from the Portuguese Institute of Rheumatology, Lisbon, Portugal, and participated voluntarily in this study. Inclusion criteria were defined as follow, to allow a coherent sample: (1) diagnosis of RA was made according to the 2010 Rheumatoid Arthritis Classification Criteria [1]; (2) patients underwent, for at least 4 weeks before, a stable dose of disease-modifying antirheumatic drugs; this period was necessary to achieve the anticipated effects of medication on joint pain and disease activity; (3) absence of early RA (disease duration <2 years); (4) diagnosis of post-menopausal status [53]; (5) absence of early menopause [54]; (6) absence of an unstable heart condition, chronic obstructive pulmonary disease or cancer; (7) absence of prosthetics in the lower limb joints; (8) nonparticipation in any kind of exercise programme in the last 3 months; and (9) documented ability to walk barefoot and unassisted for >7 m (without current walking aids).
The selected patients were allocated to the exercise group (EG) or to the control group (CG). A power analysis using GPower 3.0.10 software was performed, indicating the need of a sample of 51 subjects in each group, for an independent-samples t-test, to reach a power of 0.8, an effect size of 0.5 with the significance level adjusted to 0.05. Despite the volunteering interest for the study, some patients had logistical difficulties to move to the training centre. Therefore, to reach the greatest possible sample, the allocation process in groups cannot be random. Consequently, this process was defined as following: whenever as possible, the patients were allocated to EG until an n = 15 was attained; the patients who did not have the possibility to meet the workout schedule in EG but had in CG, were allocated to CG; then, the selected patients were allocated to CG, adding to prior allocated patients. Thus, 15 patients were allocated to EG and 12 to CG. The patients read and signed an informed consent form before their participation in the study.
EG’ subjects accomplished a proprioceptive exercises programme: 12 weeks; 3 workouts/week; 30 min/workout – 25 min of proprioceptive exercises and 5 min of stretching exercises (15 s/exercise). Proprioceptive exercises were specially designed to improve lower limbs movements, according to the description framework defined in introduction. These exercises can be viewed at http://pera.ulusofona.pt/exercise-programs/exercise-group/ and Figure 1 presents an example.
Example of an exercise used in exercise group (exercise goal: Improve proprioception related to postural stability and local motor control – Lower limb joints of the support leg and hip of the swing leg; exercise description: in single leg stand position, performed flexion and extension of the swing leg hip).
An expert of the health and exercise field controlled just one subject in each individual workout (one-on-one session). This expert, who was not blind concerning allocation process, selected the proprioceptive exercises for all subjects (from the defined exercises). The selection of each exercise was made according to its level of complexity and each subject’s capacity to perform the exercise. Exercise complexity was increased along the programme period (whenever the exercise was easily performed by the subject). 3 sets of 3 repetitions were performed in each exercise (performed under conditions without fatigue).
The selection of exercises for the CG programme presupposed that these exercises should not have any influence in the evaluated parameters. Thus, CG’ subjects accomplished the following programme: 12 weeks; 1 workout every two weeks; 30 min/workout. Each session was composed by stretching exercises for trunk and upper limbs (15 s/exercise). At http://pera.ulusofona.pt/exercise-programs/control-group/ are presented these exercises. The training sessions in this group were also performed individually (one-on-one).
The Disease Activity Score–28 joints (DAS-28) was used to assess disease activity. DAS-28 score was calculated from: number of swollen and tender joints; visual analogue scale (VAS) to assess global health; and erythrocyte sedimentation rate [55]. One experienced rheumatologist evaluated the number of swollen and tender joints and applied the VAS. Erythrocyte sedimentation rate was assessed in a laboratory. The experienced rheumatologist and the laboratory were blind in relation to allocation process. Although the emphasis of the exercise programme was on lower limbs, most joints included in DAS-28 were located in the upper limbs. Therefore, the number of swollen or tender lower limb joints was also used to assess disease activity. To complement the aforementioned data, subjects answered to a VAS to measure pain perception regarding previous day [56]. This VAS is completed in a comprehensive way to the subjects: at the beginning of every workout session a horizontal straight line of 100 mm was presented in a white paper; the end anchors of the line were labeled as “no pain” on one end and “pain as bad as it could possibly be” on the other end; subjects responded to the VAS by placing a mark through the line already defined; this mark represented the subject’s subjective pain perception regarding previous day. The VAS was scored by measuring the distance, in millimeters, between the anchor end labeled as “no pain” and the subject’s mark on the line.
The demographic characteristics as well as reproductive and medical history of each subject were also collected by the experienced rheumatologist (age, body mass, height, duration of menopause, nature of menopause, disease duration, and pharmacological therapies).
An optoelectrical 3D motion analysis was used to assess gait biomechanical parameters. The Vicon® Motion Capture MX System (VICON Motion Systems, Oxford, UK) composed by 9 MX infrared cameras (7 × 1.3 MP; 2 × 2.0 MP), was synchronized with a force plate (model BP400600, AMTI, Watertown, MA, USA).
Each trial session had distinct parts: laboratory preparation, subject preparation, and data collection. The laboratory preparation included the calibration of the system made in accordance with the Vicon® technical specifications. Kinematic data was recorded at 200 Hz and ground reaction force data at 1000 Hz.
Subject preparation started with the collection of anthropometric data and the placement of 39 spherical reflective markers (9.5 mm diameter) that compose the Plug-In Gait Full-Body model (VICON Motion Systems, Oxford, UK). To assure the same measure and marker placement criteria, these tasks were performed by the same team researcher, who was not blind to the allocation process. The collection of the anthropometric data was carried out using a SECA 764 station (Hamburg Germany) and Siber-Hegner instruments (Siber & Hegner, Zurich, Switzerland).
Kinematic and kinetic data was recorded using the Vicon Nexus software (version 1.7.1). The test protocol used the guidelines specified in previous studies [14, 17]: (1) subjects walked barefoot in a gait corridor of 7 m long and 2 m wide, on which the force platform was mounted; (2) at the end of the corridor, the subjects turned around; (3) subjects were asked to walk at a natural and self-selected speed – representing the most comfortable walking speed that minimized possible discomfort that could have been caused if a pre-determined speed was determined [57] and minimized the induction of subjects into a transitioning stage, that is, a stage marked by an increased variability [58]; (4) seven valid trials of the gait stance phase were collected for each foot (trials were considered valid only when one foot stepped entirety on the force plate; this information was not given to the subjects to avoid changes in individual gait patterns); and (5) to avoid gait performance deterioration related to fatigue, subjects rested for 2 min by sitting on a chair every 20 trials.
All trials were processed using the Vicon Nexus software (version 1.7.1) and a quintic spline routine (Woltring filtering) was applied. The next gait biomechanical parameters were evaluated in the stride that started at heel strike on force plate: gait speed (m/s) – determined as described in a previous study [59]; stance phase time (s); time of the controlled plantar flexion sub-phase (s); time of the controlled dorsiflexion sub-phase (s); time of the powered plantar flexion sub-phase (s); ankle angular position in sagittal plane at the – heel strike (°), final of the controlled plantar flexion sub-phase (°), final of the controlled dorsiflexion sub-phase (°), toe off (°) – in these four angular positions, positive values means dorsiflexion and negative values means plantar flexion; ankle angular displacement along the – controlled plantar flexion sub-phase (°), controlled dorsiflexion sub-phase (°), and powered plantar flexion sub-phase (°); ankle moment of force peak in sagittal plane (Nm/kg); and ankle power peak (W/kg).
For this study, an octopolar bioimpedance spectroscopy analyzer (InBody 720, Biospace, Korea) was used to assess body composition. This equipment analyses independently five body sections (i.e., trunk, both upper limbs, and both lower limbs). In a previous study [60], the accuracy of InBody 720 was tested using energy X-ray absorptiometry as a reference standard. Data revealed, in females, excellent agreements between InBody 720 and dual-energy X-ray for the quantification of the lower limb muscle mass (intraclass correlation coefficient ≥ 0.83) and percentage of fat mass (intraclass correlation coefficient = 0.93). Therefore, in this study were evaluated the muscle mass values (kg and % of total body mass) and the percentage of fat mass (%). These data was included in this chapter in order to improve the quality of the discussion. These assessments were carried out in accordance with the procedures presented in the equipment user manual [61].
In patients with RA, right and left lower limb joints can be differently affected during the course of the disease. Accordingly, intra-individual differences between lower limbs of post-menopausal women with RA, concerning ankle kinematics and kinetics, were observed in a prior study [14]. Consequently, randomly selected and measured only one lower limb per subject could conduct to loss of valuable information. According to literature [62], the statistical analyses should consider both sides for analyses when right and left lower limbs are independent. Therefore, each limb/ankle/foot dataset was independently considered for the statistical analyses. To this end, the mean and the coefficient of variation (CV) of the biomechanical parameters of each ankle/foot were calculated (from the seven trials collected for the contact of each foot on force plate). These data were inserted in the SPSS software for Windows, version 17 (SPSS, Inc., Chicago, IL), in order to perform the statistical analyses. Variability was studied through the CV.
The t-test’s significance level can be almost exact for sample sizes greater than 12, even if the distribution was not normal [63]. Therefore, a two-tailed paired-samples t-test was used to compare baseline and post intervention in each group. For the purpose of comparison between groups after intervention, the differences between baseline and post intervention were viewed as variables. A two-tailed independent-samples t-test was used to compare groups at baseline and post intervention. Differences were considered statistically significant at p values <0.05.
One withdrawal was registered in EG: the post-menopausal woman with RA failed to meet the training schedule, precluding her inclusion in statistical analyses. Thus, in the EG only fourteen post-menopausal women with RA were included in the statistical analyses. In EG and CG, the rate of adherence to the programme was 86.1 ± 10.5% and 95.8 ± 27.5%, respectively.
Table 1 presents the descriptive statistics of the clinical, demographic, and body composition data for EG and CG, at baseline and post exercises programmes. In these parameters no statistically significant intergroup difference was found at baseline.
Parameters | EG (n = 14) | CG (n = 12) | ||||
---|---|---|---|---|---|---|
Baseline mean (sd) | Post mean (sd) | p value | Baseline mean (sd) | Post mean (sd) | p value | |
Age (years) | 62.2 (8.8) | — | 67.8 (6.6) | — | ||
Disease duration (years) | 9.3 (9.5) | — | 11.6 (9.9) | — | ||
Duration of menopause (years) | 14.8 (8.3) | — | 19.0 (9.6) | — | ||
DAS-28 score | 4.6 (1.5) | 4.0 (1.3) | 0.059 | 4.6 (1.2) | 4.2 (0.9) | 0.097 |
Number tender or swollen joints1 | 9.0 (10.3) | 6.4 (9.1) | 0.069 | 6.1 (5.2) | 3.8 (5.5) | 0.084 |
VAS (mm) | 47.0 (18.2) | 21.1 (13.9) | 0.000 | 53.0 (14.3) | 47.4 (19.8) | 0.348 |
Body mass (kg) | 67.5 (15.3) | 66.4 (14.6) | 0.023 | 63.2 (10.0) | 63.7 (10.1) | 0.168 |
Height (m) | 1.53 (0.06) | — | 1.52 (0.05) | — | ||
Body mass index (kg/m2) | 29.0 (5.9) | 28.5 (5.7) | 0.025 | 27.4 (4.3) | 27.6 (4.4) | 0.140 |
Fat mass (%) | 36.9 (7.7) | 36.1 (8.1) | 0.508 | 34.9 (7.1) | 36.0 (6.2) | 0.381 |
Lower limbs muscle mass (kg) | 12.0 (0.8) | 12.0 (0.9) | 0.926 | 11.4 (0.9) | 11.4 (1.0) | 0.873 |
Lower limbs muscle mass (%) | 18.2 (2.5) | 18.5 (3.1) | 0.417 | 18.2 (2.1) | 18.4 (2.5) | 0.739 |
Clinical, demographic, and body composition data at baseline and post intervention.
lower limb joints.
CG – control group; DAS-28 – Disease Activity Score (28 joints); EG – exercise group; p value – differences between baseline and post intervention were considered statistically significant at p values <0.05; sd – standard deviation; VAS – visual analogue scale to measure pain perception in relation to previous day.
Most of the post-menopausal woman with RA, in both groups, presented at least one swollen or tender lower limb joint: one in EG and two in CG had no swollen or tender joints to report. One post-menopausal woman with RA in EG and two in CG had an induced menopause (i.e., bi-lateral oophorectomy) – remaining women had a natural menopause. Furthermore, two post-menopausal women with RA in each group were undergoing hormone therapy. Eleven post-menopausal women with RA in EG and nine in CG were using glucocorticoids.
Between baseline and post exercises programmes, both groups presented a tendency to reduction in the DAS-28 score, as well as in the number of tender or swollen lower limb joints. Between the first and last workout session, the EG’ subjects presented a decrease of the value of the VAS to measure pain perception regarding previous day (p < 0.001). Figure 2 shows this reduction along the proprioceptive exercises programme sessions. In the CG, no statistically significant difference between the first and last workout session was observed.
Mean ± standard deviation curves of the visual analogue scale to measure pain perception regarding previous day [
Concerning body composition, no differences were observed between baseline and post exercises programmes in both groups.
Table 2 describes the gait biomechanical data at baseline and post exercises programmes. At baseline, no statistically significant intergroup difference was found. Figure 3 presents the curves of the ankle power and ankle moment of force of both groups, during the stance phase.
Parameters | EG (n = 28) | CG (n = 24) | p value | ||||
---|---|---|---|---|---|---|---|
Baseline mean (sd) | Post mean (sd) | Δ mean (sd) | Baseline mean (sd) | Post mean (sd) | Δ mean (sd) | ||
Gait speed (m/s) | 0.97 (0.20) | 1.01 (0.18) | 0.05 (0.10)† | 0.96 (0.24) | 0.95 (0.24) | −0.01 (0.07) | 0.028* |
Stance phase time (s) | 0.70 (0.08) | 0.67 (0.08) | −0.02 (0.05)† | 0.71 (0.11) | 0.72 (0.11) | 0.01 (0.08) | 0.007* |
Time (s) | 0.06 (0.01) | 0.06 (0.01) | 0.00 (0.01) | 0.05 (0.01) | 0.05 (0.01) | 0.00 (0.00) | 0.701 |
Ankle angular position at beginning of phase (°) | −5.1 (4.0) | −4.3 (3.5) | 0.7 (3.0) | −4.9 (3.7) | −4.4 (4.3) | 0.6 (2.3) | 0.846 |
Ankle angular position at end of phase (°) | −9.2 (3.6) | −8.9 (3.2) | 0.2 (3.2) | −8.5 (4.0) | −8.4 (5.3) | 0.2 (2.5) | 0.998 |
Ankle angular displacement (°) | 4.1 (2.6) | 4.6 (2.3) | 0.5 (1.6) | 3.6 (1.8) | 4.0 (2.5) | 0.4 (1.3) | 0.803 |
Time (s) | 0.49 (0.07) | 0.47 (0.08) | −0.02 (0.04)‡ | 0.49 (0.11) | 0.50 (0.11) | 0.00 (0.03) | 0.027* |
Ankle angular position at beginning of phase (°) | −9.2 (3.6) | −8.9 (3.2) | 0.2 (3.2) | −8.5 (4.0) | −8.4 (5.3) | 0.2 (2.5) | 0.998 |
Ankle angular position at end of phase (°) | 13.1 (3.3) | 11.9 (3.9) | −1.1 (3.5) | 13.6 (3.8) | 13.8 (3.4) | 0.2 (1.9) | 0.124 |
Ankle angular displacement (°) | 22.3 (3.5) | 20.9 (4.7) | −1.4 (3.7) | 22.1 (5.6) | 22.1 (6.1) | 0.0 (2.6) | 0.135 |
Time (s) | 0.15 (0.02) | 0.15 (0.03) | 0.00 (0.02) | 0.16 (0.03) | 0.17 (0.03) | 0.01 (0.03)† | 0.060 |
Ankle angular position at beginning of phase (°) | 13.1 (3.3) | 11.9 (3.9) | −1.1 (3.5) | 13.6 (3.8) | 13.8 (3.4) | 0.2 (1.9) | 0.124 |
Ankle angular position at end of phase (°) | −9.3 (7.1) | −10.3 (6.0) | −1.1 (4.6) | −8.6 (6.7) | −9.4 (6.9) | −0.8 (3.5) | 0.793 |
Ankle angular displacement (°) | 22.4 (6.2) | 22.2 (5.3) | −0.1 (4.6) | 22.2 (6.4) | 23.1 (6.9) | 0.9 (3.9) | 0.372 |
Ankle moment of force peak (Nm/kg) | 1.12 (0.18) | 1.16 (0.19) | 0.03 (0.16) | 1.08 (0.22) | 1.09 (0.22) | 0.01 (0.08) | 0.587 |
Ankle power peak (W/kg) | 2.34 (0.91) | 2.60 (0.79) | 0.27 (0.55)† | 2.27 (1.10) | 2.27 (0.98) | −0.01 (0.32) | 0.043* |
Gait biomechanical data at baseline and post exercises programmes.
p < 0.05 (differences between baseline and post intervention.
p < 0.01 (differences between baseline and post intervention).
p < 0.05.
Ankle angular position is positive during dorsiflexion and negative during plantar flexion; CG – control group; EG – exercise group; p value – differences between groups concerning Δ; sd – standard deviation; Δ – difference between baseline and post exercises programme.
Mean ± standard deviation curves of the ankle power and ankle moment of force of both groups, during the stance phase (normalized to 100% of the stance phase).
Between baseline and post intervention, EG’ subjects yielded a higher gait speed (p = 0.027), a shorter stance phase (p = 0.014), a shorter controlled dorsiflexion sub-phase (p = 0.009), and a greater ankle power peak (p = 0.016). A trend towards reduction in ankle angular position at final controlled dorsiflexion sub-phase and in ankle angular displacement during controlled dorsiflexion sub-phase were observed in EG (p = 0.090 and p = 0.059, respectively). In the other gait biomechanical parameters of the EG’ subjects, no statistically significant intragroup differences were found.
In CG, no statistically significant differences were found in gait biomechanical parameters after intervention, except for an increase of the time of powered plantar flexion sub-phase (p = 0.043).
Contrary to baseline, intergroup differences were found after intervention in gait speed, stance phase time, time of controlled dorsiflexion sub-phase, and ankle power peak (p < 0.05).
Variability of the gait biomechanical parameters showed no statistically significant intergroup or intragroup differences at baseline and post exercises programmes.
A number of systematic reviews and meta-analysis [44, 45, 46, 47] described the safety of using aerobic exercises, strength exercises, and the combination of both in patients with RA. Nonetheless, there was a need of researches that evaluate the effects of proprioceptive exercises on disease activity of patients with RA. Therefore, the first aim of this study was to describe the effects of a proprioceptive exercises programme on the disease activity of post-menopausal women with RA. Data from this study (DAS-28 and number of swollen or tender lower limb joints) showed no disease activity increase as a result of the exercise programme implementation; quite the reverse, data showed a trend towards reduction. Moreover, EG’ subjects presented a reduction of the pain perception between the beginning and ending of the proprioceptive exercises programme. These results indicate that is safe to use proprioceptive exercises in post-menopausal women with RA.
A second aim was to evaluate the effects of the programme on ankle kinematics and kinetics of post-menopausal women with RA, during the gait stance phase. To the best of our knowledge, this was the first study that researched this topic in patients with RA, and specifically in post-menopausal women with RA. Data showed that a proprioceptive exercises programme had effects on ankle kinematics and ankle kinetics, as well as on gait speed, i.e.: higher gait speed, shorter stance phase and controlled dorsiflexion sub-phase, and higher ankle power peak. Otherwise, CG’ subjects presented no changes post intervention. These results corroborated those of a prior study [50], which also found an increase of gait speed in elderly women after the participation in a proprioceptive training programme. Moreover, elderly also improved postural control after a proprioceptive exercises programme [49, 51]. However, none of them studied the effects of these programmes on ankle kinematics and kinetics during gait. As concluded in a recent study [14], post-menopausal women with RA should improve ankle kinematic and kinetic parameters during the propulsive phase of gait, which are important parameters for foot function, functional capacity, and fall prevention. Therefore, data presented in this study showed that a proprioceptive exercises programme had effects on those parameters, namely on the stance phase duration, controlled dorsiflexion sub-phase duration, and ankle power peak value. Thus, the improvement in foot function after the proprioceptive exercise programmes seems to point out that using this kind of interventions is indicated as an option for therapy in post-menopausal women with RA.
According to literature [14, 21, 22, 23, 24], a lower ankle power and moment of force peaks were observed in patients with RA, and specifically in post-menopausal women with RA. Therefore, interventions to improve these gait biomechanical parameters are desirable, with exercises programmes being a possible option, namely proprioceptive exercise programmes. In the present study, post-menopausal women with RA yielded a higher ankle power peak as a result of the proprioceptive exercises programme; nonetheless, the ankle moment of force peak showed no change. Thus, the proprioceptive exercises programme enhanced joint power of the post-menopausal women with RA during the powered plantar flexion sub-phase, a parameter that may play an important role in the risk of fall. Otherwise, the inability of this programme to enhance muscle mass and ankle moment of force peak may indicate another reason is behind of the better performance during the powered plantar flexion sub-phase. According to a systematic review [38], there is evidence that proprioceptive exercises programmes can lead to improvements in proprioception and somatosensory function. According to this, we can speculate that the reason for a better performance was an improvement of proprioception and motor control as a result of the proprioceptive exercises programme.
Another aim was to evaluate the effects of the proprioceptive exercises programme on the ankle biomechanical variability. According to literature, an increased stride-to-stride variability was attributed to a probable loss of motor control [29] and post-menopausal women with RA yielded an increased variability of the ankle moment of force peak [14]. In this study, it was conjectured that the variability of the ankle moment of force peak could be decreased as consequence of the proprioceptive exercises programme; however, data showed no differences between pre and post intervention. Thus, another question arises, which can be answered by future research: “Could other kind of exercises programmes change variability of ankle kinematic and kinetic parameters during the gait stance phase?”
Strength training enhanced muscle mass of patients with RA [64, 65], however, the effect of a proprioceptive exercise programme on muscle mass was unknown. Between baseline and post exercise programmes, data showed no changes in low limbs muscle mass, pointing that these types of programmes had no effect on this parameter. Nonetheless, more research is required to clarify this question. On the other hand, post-menopausal hormone therapy, vitamin D and protein intakes, and menopause nature can influence muscle status [66, 67]. The use of hormone therapy could influence positively muscle status, whereas an induced menopause (e.g., bilateral oophorectomy) could be responsible of a greater impairment of muscle status. These parameters were not considered along the selection and allocation processes; nevertheless, data revealed that both groups of post-menopausal women with RA presented similar characteristics. Higher vitamin D and protein intakes could restrict muscle fiber atrophy; nonetheless, these variables were not evaluated in this study and thus, it can be considered as a limitation.
The presence of higher fat mass values could predispose to hypertension, diabetes, and risk for cardiovascular disease [68] and patients with RA showed high percentages of fat mass [69, 70, 71, 72]. Fat tissue is an important font of inflammatory cytokines that could contribute to the systemic inflammation [72]. Following this deduction, it would be important to reduce fat mass in patients with RA, and to achieve this, physical exercise appears as an important strategy. However, the proprioceptive exercises programmes assessed in our study had no effect on fat mass of post-menopausal women with RA. To the best of our knowledge, this was the first study that researched this issue. Previous studies researched the effects of other types of physical exercise on fat mass of patients with RA. Two studies showed no change of the fat mass after strength training programmes [65, 73]. Otherwise, a combined strength and endurance training programme decreased the subcutaneous fat thickness and this should not be dissociated from the inclusion of aerobic exercises in the training programme [74]. Accordingly, aerobic exercises are the best option for decreasing fat mass [75]. The importance of proprioceptive exercises is recognized with the findings showed in the present study; however, as described in literature [64], an exercise programme for patients with RA must contain aerobic, strength, mobility and proprioceptive exercises to achieve all benefits.
According to the literature [47], exercises programmes for patients with RA should be cautiously designed to the individual. The methodology of our exercise programme followed this indication. However, according to a number of systematic reviews [44, 45, 46, 47, 48], most studies that evaluated the effects of physical exercise on patients with RA applied group training sessions in their programmes. Consequently, it is imperative to emphasize the kind of exercise programme used in the present research (an individualized and personalized exercise programme). In the present study, the one-on-one workout sessions could have contributed to the high adherence rates of the programmes and to the observed results. Moreover, the clinical community can easily apply a similar programme due to the type of equipment used, i.e., low-cost equipment.
In accordance with the aforementioned, the use of proprioceptive exercise in clinical practice with women with RA is suggested, especially in patients in the following situations: patients with low physical activity; after periods of immobility; in recovery phases from an active disease; in aftercare for joint replacement surgery (total hip or knee prosthesis); in elderly patients, those with rheumatoid cachexia, those with a history of falls; after the first fracture; and in patients with moderate to severe osteoporosis.
A proprioceptive exercises programme had effects on the ankle biomechanical performance of post-menopausal women with RA, during the gait stance phase: increasing ankle power peak and shortening controlled dorsiflexion sub-phase. The programme also increased gait speed and shortened stance phase, although it had no effects on body composition. Finally, it seems to be safe in post-menopausal women with RA.
The authors declare no conflict of interest.